[369] THE DUAL EGF-A/EGF-RECEPTOR TYROSINE KINASE INHIBITOR AEE-788 INHIBITS GROWTH OF HUMAN HEPATOCELLULAR CARCINOMA XENOGRAFTS IN MICE (English)
- New search for: Ocker, M.
- New search for: Okamoto, K.
- New search for: Neureiter, D.
- New search for: Kaufmann, B.
- New search for: Haus, U.
- New search for: Herold, C.
- New search for: Ocker, M.
- New search for: Okamoto, K.
- New search for: Neureiter, D.
- New search for: Kaufmann, B.
- New search for: Haus, U.
- New search for: Herold, C.
In:
JOURNAL OF HEPATOLOGY
;
46
;
S143-S144
;
2007
-
ISSN:
- Article (Journal) / Print
-
Title:[369] THE DUAL EGF-A/EGF-RECEPTOR TYROSINE KINASE INHIBITOR AEE-788 INHIBITS GROWTH OF HUMAN HEPATOCELLULAR CARCINOMA XENOGRAFTS IN MICE
-
Contributors:Ocker, M. ( author ) / Okamoto, K. ( author ) / Neureiter, D. ( author ) / Kaufmann, B. ( author ) / Haus, U. ( author ) / Herold, C. ( author )
-
Published in:JOURNAL OF HEPATOLOGY ; 46 ; S143-S144
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2007-01-01
-
Size:S143-S144
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.3623
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.3623 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 46
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Going towards more relevant cell culture models to study the in vitro replication of serum-derived hepatitis C virus and virus/host cell interactions?Durantel, D. / Zoulim, F. et al. | 2007
- 6
-
Does treatment with interferon-based therapy improve the natural history of chronic hepatitis B infection?Lau, G. K. et al. | 2007
- 9
-
In the new area of noninvasive markers of hepatocellular carcinomaParadis, V. / Bedossa, P. et al. | 2007
- 12
-
Leptin and liver tissue repair: Do rodent models provide the answers?Marra, F. et al. | 2007
- 19
-
Outbreak of hepatitis C virus infection during sclerotherapy of varicose veins: Long-term follow-up of 196 patients (4535 patient-years)de Ledinghen, V. / Trimoulet, P. / Mannant, P. R. / Dumas, F. / Champbenoit, P. / Baldit, C. / Foucher, J. / Faure, M. / Vergniol, J. / Castera, L. et al. | 2007
- 26
-
Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytesAly, H. H. / Watashi, K. / Hijikata, M. / Kaneko, H. / Takada, Y. / Egawa, H. / Uemoto, S. / Shimotohno, K. et al. | 2007
- 37
-
Clinical evaluation (Phase I) of a human monoclonal antibody against hepatitis C virus: Safety and antiviral activityGalun, E. / Terrault, N. A. / Eren, R. / Zauberman, A. / Nussbaum, O. / Terkieltaub, D. / Zohar, M. / Buchnik, R. / Ackerman, Z. / Safadi, R. et al. | 2007
- 45
-
Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinomaLin, S. M. / Yu, M. L. / Lee, C. M. / Chien, R. N. / Sheen, I. S. / Chu, C. M. / Liaw, Y. F. et al. | 2007
- 53
-
Intracellular accumulation of hepatitis C virus proteins in a human hepatoma cell lineBrazzoli, M. / Crotta, S. / Bianchi, A. / Bagnoli, F. / Monaghan, P. / Wileman, T. / Abrignani, S. / Merola, M. et al. | 2007
- 60
-
Long-term portosystemic shunt patency as a determinant of outcome in Budd-Chiari syndromeBachet, J. B. / Condat, B. / Hagege, H. / Plessier, A. / Consigny, Y. / Belghiti, J. / Valla, D. et al. | 2007
- 69
-
Pravastatin reduces lung metastasis of rat hepatocellular carcinoma via a coordinated decrease of MMP expression and activityTaras, D. / Blanc, J. F. / Rullier, A. / Dugot-Senant, N. / Laurendeau, I. / Vidaud, M. / Rosenbaum, J. et al. | 2007
- 77
-
Role of the Fas/FasL pathway in combination therapy with interferon-a and fluorouracil against hepatocellular carcinoma in vitroNakamura, M. / Nagano, H. / Sakon, M. / Yamamoto, T. / Ota, H. / Wada, H. / Damdinsuren, B. / Noda, T. / Marubashi, S. / Miyamoto, A. et al. | 2007
- 89
-
Prospero-related homeobox 1 (PROX1) is frequently inactivated by genomic deletions and epigenetic silencing in carcinomas of the bilary systemLaerm, A. / Helmbold, P. / Goldberg, M. / Dammann, R. / Holzhausen, H. J. / Ballhausen, W. G. et al. | 2007
- 98
-
Complete eradication of hepatocellular carcinomas by combined vasostatin gene therapy and B7H3-mediated immunotherapyMa, L. / Luo, L. / Qiao, H. / Dong, X. / Pan, S. / Jiang, H. / Krissansen, G. W. / Sun, X. et al. | 2007
- 107
-
Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinomaZhang, J. Y. / Megliorino, R. / Peng, X. X. / Tan, E. M. / Chen, Y. / Chan, E. K. et al. | 2007
- 115
-
Rosiglitazone attenuates suppression of RXRa-dependent gene expression in inflamed liverGhose, R. / Mulder, J. / von Furstenberg, R. J. / Thevananther, S. / Kuipers, F. / Karpen, S. J. et al. | 2007
- 124
-
Leptin represses matrix metalloproteinase-1 gene expression in LX2 human hepatic stellate cellsCao, Q. / Mak, K. M. / Lieber, C. S. et al. | 2007
- 134
-
Attenuated liver progenitor (oval) cell and fibrogenic responses to the choline deficient, ethionine supplemented diet in the BALB/c inbred strain of miceKnight, B. / Akhurst, B. / Matthews, V. B. / Ruddell, R. G. / Ramm, G. A. / Abraham, L. J. / Olynyk, J. K. / Yeoh, G. C. et al. | 2007
- 142
-
Fibrogenic cell fate during fibrotic tissue remodelling observed in rat and human cultured liver slicesGuyot, C. / Combe, C. / Balabaud, C. / Bioulac-Sage, P. / Desmouliere, A. et al. | 2007
- 151
-
Hyperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in miceHamelet, J. / Demuth, K. / Paul, J. L. / Delabar, J. M. / Janel, N. et al. | 2007
- 160
-
Occult hepatitis B virus infectionRaimondo, G. / Pollicino, T. / Cacciola, I. / Squadrito, G. et al. | 2007
- 171
-
Tolerability of Peg interferon-a2b and Ribavirin therapy in patients with chronic hepatitis C and glucose-6-phosphate dehydrogenase deficiencyDemelia, L. / Civolani, A. / Murgia, D. / Murru, A. / Sorbello, O. / Rizzetto, M. et al. | 2007
- 174
-
Curative bone marrow transplantation in erythropoietic protoporphyria after reversal of severe cholestasisWahlin, S. / Aschan, J. / Bjornstedt, M. / Broome, U. / Harper, P. et al. | 2007
- 180
-
Reefer madness? Assessing the effects of cannabinoids with a less jaundiced eyeFriedman, S. L. et al. | 2007
- 183
-
Announcements| 2007
- 184
-
Peer Review Policy| 2007
- 185
-
Antiviral therapy in HCV decompensated cirrhosis: To treat or not to treat?Navasa, M. / Forns, X. et al. | 2007
- 189
-
Todralazine hepatotoxicity: A sting in the histone tailElsharkawy, A. M. et al. | 2007
- 193
-
Potential role of antioxidants in the treatment of portal hypertensionRodriguez-Vilarrupla, A. / Bosch, J. / Garcia-Pagan, J. C. et al. | 2007
- 198
-
Polymorphisms of type I interferon receptor 1 promoter and their effects on chronic hepatitis B virus infectionZhou, J. / Lu, L. / Yuen, M. F. / Lam, T. W. / Chung, C. P. / Lam, C. L. / Zhang, B. / Wang, S. / Chen, Y. / Wu, S. H. et al. | 2007
- 206
-
Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: A controlled studyIacobellis, A. / Siciliano, M. / Perri, F. / Annicchiarico, B. E. / Leandro, G. / Caruso, N. / Accadia, L. / Bombardieri, G. / Andriulli, A. et al. | 2007
- 213
-
Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascitesKalambokis, G. / Fotopoulos, A. / Economou, M. / Pappas, K. / Tsianos, E. V. et al. | 2007
- 222
-
Tannic acid synergizes the cytotoxicity of chemotherapeutic drugs in human cholangiocarcinoma by modulating drug efflux pathwaysNaus, P. J. / Henson, R. / Bleeker, G. / Wehbe, H. / Meng, F. / Patel, T. et al. | 2007
- 230
-
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient miceZamara, E. / Galastri, S. / Aleffi, S. / Petrai, I. / Aragno, M. / Mastrocola, R. / Novo, E. / Bertolani, C. / Milani, S. / Vizzutti, F. et al. | 2007
- 239
-
Marked changes of the hepatic sinusoid in a transgenic mouse model of acute immune-mediated hepatitisWarren, A. / Bertolino, P. / Benseler, V. / Fraser, R. / McCaughan, G. W. / Le Couteur, D. G. et al. | 2007
- 247
-
Remodelling of calcium signalling during liver regeneration in the ratNicou, A. / Serriere, V. / Hilly, M. / Prigent, S. / Combettes, L. / Guillon, G. / Tordjmann, T. et al. | 2007
- 257
-
The murine liver is a potential target organ for IL-19, IL-20 and IL-24: Type I Interferons and LPS regulate the expression of IL-20R2Wegenka, U. M. / Dikopoulos, N. / Reimann, J. / Adler, G. / Wahl, C. et al. | 2007
- 266
-
Overexpression of the gene for transmembrane 4 superfamily member 4 accelerates liver damage in rats treated with CCl4Qiu, J. / Liu, Z. / Da, L. / Li, Y. / Xuan, H. / Lin, Q. / Li, F. / Wang, Y. / Li, Z. / Zhao, M. et al. | 2007
- 276
-
LPS exacerbates endothelin-1 induced activation of cytosolic phospholipase A2 and thromboxane A2 production from Kupffer cells of the prefibrotic rat liverMiller, A. M. / Masrorpour, M. / Klaus, C. / Zhang, J. X. et al. | 2007
- 286
-
Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the ratAbe, W. / Ikejima, K. / Lang, T. / Okumura, K. / Enomoto, N. / Kitamura, T. / Takei, Y. / Sato, N. et al. | 2007
- 295
-
IFN-g abrogates profibrogenic TGF-b signaling in liver by targeting expression of inhibitory and receptor SmadsWeng, H. / Mertens, P. R. / Gressner, A. M. / Dooley, S. et al. | 2007
- 304
-
NADPH oxidase is not an essential mediator of oxidative stress or liver injury in murine MCD diet-induced steatohepatitisdela Pena, A. / Leclercq, I. A. / Williams, J. / Farrell, G. C. et al. | 2007
- 314
-
Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathwayKharbanda, K. K. / Mailliard, M. E. / Baldwin, C. R. / Beckenhauer, H. C. / Sorrell, M. F. / Tuma, D. J. et al. | 2007
- 322
-
A novel mechanism for drug-induced liver failure: Inhibition of histone acetylation by hydralazine derivativesMurata, K. / Hamada, M. / Sugimoto, K. / Nakano, T. et al. | 2007
- 330
-
Repeated whiskey binges promote liver injury in rats fed a choline-deficient dietNieto, N. / Rojkind, M. et al. | 2007
- 340
-
Liver transplantation in childrenMuiesan, P. / Vergani, D. / Mieli-Vergani, G. et al. | 2007
- 349
-
Reply to Dr. Sierra's letter on COMPARE studySilva, M. et al. | 2007
- 349
-
Peginterferon alfa-2b vs. peginterferon alfa-2a in the treatment of hepatitis C, is there any difference?Sierra, F. et al. | 2007
- 350
-
Reply to issues raised in the Jansen/Reesink editorialSilva, M. et al. | 2007
- 352
-
Epigenetic mechanism of stellate cell trans-differentiationTsukamoto, H. et al. | 2007
- 355
-
In vitro veritas? The challenges of studying hepatitis C virus infectivity in a test tubevon Hahn, T. / McKeating, J. A. et al. | 2007
- 359
-
Antiviral therapy in liver transplant recipients: Is SVR the only endpoint that matters?Kuo, A. / Terrault, N. A. et al. | 2007
- 362
-
Interventional radiology as a fine artBeaugrand, M. / Trinchet, J. C. et al. | 2007
- 365
-
New perspectives for the treatment of cholestasis:Lessons from basic science applied clinicallyBoyer, J. L. et al. | 2007
- 372
-
Gender-dependent association of CTLA4 polymorphisms with resolution of hepatitis C virus infectionSchott, E. / Witt, H. / Hinrichsen, H. / Neumann, K. / Weich, V. / Bergk, A. / Halangk, J. / Muller, T. / Tinjala, S. / Puhl, G. et al. | 2007
- 381
-
Polymorphisms of interleukin-1b in Japanese patients with hepatitis B virus infectionMigita, K. / Maeda, Y. / Abiru, S. / Nakamura, M. / Komori, A. / Miyazoe, S. / Nakao, K. / Yatsuhashi, H. / Eguchi, K. / Ishibashi, H. et al. | 2007
- 387
-
Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and deathKumar Acharya, S. / Kumar Sharma, P. / Singh, R. / Kumar Mohanty, S. / Madan, K. / Kumar Jha, J. / Kumar Panda, S. et al. | 2007
- 395
-
Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis CHalfon, P. / Bacq, Y. / De Muret, A. / Penaranda, G. / Bourliere, M. / Ouzan, D. / Tran, A. / Botta, D. / Renou, C. / Brechot, M. C. et al. | 2007
- 403
-
Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levelsAkuta, N. / Suzuki, F. / Kawamura, Y. / Yatsuji, H. / Sezaki, H. / Suzuki, Y. / Hosaka, T. / Kobayashi, M. / Arase, Y. et al. | 2007
- 411
-
The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virusMolina, S. / Castet, V. / Fournier-Wirth, C. / Pichard-Garcia, L. / Avner, R. / Harats, D. / Roitelman, J. / Barbaras, R. / Graber, P. / Ghersa, P. et al. | 2007
- 420
-
Health-related quality of life in patients with chronic hepatitis C and advanced fibrosisBonkovsky, H. L. / Snow, K. K. / Malet, P. F. / Back-Madruga, C. / Fontana, R. J. / Sterling, R. K. / Kulig, C. C. / Di Bisceglie, A. M. / Morgan, T. R. / Dienstag, J. L. et al. | 2007
- 432
-
Reduced susceptibility to epinephrine-induced arrhythmias in cirrhotic rats: The roles of nitric oxide and endogenous opioid peptidesTavakoli, S. / Hajrasouliha, A. R. / Jabehdar-Maralani, P. / Ebrahimi, F. / Solhpour, A. / Sadeghipour, H. / Ghasemi, M. / Dehpour, A. R. et al. | 2007
- 440
-
Impaired extracellular matrix degradation in aortic vessels of cirrhotic ratsFernandez-Varo, G. / Morales-Ruiz, M. / Ros, J. / Tugues, S. / Munoz-Luque, J. / Casals, G. / Arroyo, V. / Rodes, J. / Jimenez, W. et al. | 2007
- 447
-
Spatio-temporal decomposition of the electroencephalogram in patients with cirrhosisMontagnese, S. / Jackson, C. / Morgan, M. Y. et al. | 2007
- 459
-
Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantationPicciotto, F. P. / Tritto, G. / Lanza, A. G. / Addario, L. / De Luca, M. / Di Costanzo, G. / Lampasi, F. / Tartaglione, M. T. / Marsilia, G. M. / Calise, F. et al. | 2007
- 466
-
Amanita phalloides poisoning: Reassessment of prognostic factors and indications for emergency liver transplantationEscudie, L. / Francoz, C. / Vinel, J. P. / Moucari, R. / Cournot, M. / Paradis, V. / Sauvanet, A. / Belghiti, J. / Valla, D. / Bernuau, J. et al. | 2007
- 474
-
Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokineticsVarela, M. / Real, M. I. / Burrel, M. / Forner, A. / Sala, M. / Brunet, M. / Ayuso, C. / Castells, L. / Montana, X. / Llovet, J. M. et al. | 2007
- 482
-
Liver-homing of purified glucose oxidase: A novel in vivo model of physiological hepatic oxidative stress (H2O2)Rost, D. / Welker, A. / Welker, J. / Millonig, G. / Berger, I. / Autschbach, F. / Schuppan, D. / Mueller, S. et al. | 2007
- 492
-
Glycogen storage disease type III-hepatocellular carcinoma a long-term complication?Demo, E. / Frush, D. / Gottfried, M. / Koepke, J. / Boney, A. / Bali, D. / Chen, Y. T. / Kishnani, P. S. et al. | 2007
- 499
-
Liver involvement in hereditary hemorrhagic telangiectasia (HHT)Garcia-Tsao, G. et al. | 2007
- 508
-
Immunological techniques in viral hepatitisRehermann, B. / Naoumov, N. V. et al. | 2007
- 521
-
Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux updateBioulac-Sage, P. / Balabaud, C. / Bedossa, P. / Scoazec, J. Y. / Chiche, L. / Dhillon, A. P. / Ferrell, L. / Paradis, V. / Roskams, T. / Vilgrain, V. et al. | 2007
- 528
-
Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: Time for new guidelines?Castera, L. / Denis, J. / Babany, G. / Roudot-Thoraval, F. et al. | 2007
- 529
-
Non-invasive markers of liver fibrosis: How to use them in clinical practice?Sebastiani, G. / Alberti, A. et al. | 2007
- 531
-
Stepwise process for the development of entecavir resistance in a chronic hepatitis B virus infected patientVillet, S. / Ollivet, A. / Pichoud, C. / Barraud, L. / Villeneuve, J. P. / Trepo, C. / Zoulim, F. et al. | 2007
- 539
-
A liver revival featuring bile acidsHouten, S. M. et al. | 2007
- 543
-
Technology evaluation: A critical step in the clinical utilization of novel diagnostic tests for liver fibrosisAfdhal, N. H. / Curry, M. et al. | 2007
- 546
-
Tumor suppressors in hepatocellular carcinoma: Many are called, but few are chosenBuendia, M. A. et al. | 2007
- 549
-
Ferritin, metabolic syndrome and NAFLD: Elective attractions and dangerous liaisonsTrombini, P. / Piperno, A. et al. | 2007
- 553
-
Acute liver failure: Where are the challenges?Clavien, P. A. et al. | 2007
- 554
-
How to decide when to list a patient with acute liver failure for liver transplantation? Clichy or King's College criteria, or something else?Renner, E. L. et al. | 2007
- 557
-
Acute liver failure: Bridging to transplant or recovery- are we there yet?Singhal, A. / Neuberger, J. et al. | 2007
- 564
-
Brain edema in acute liver failure: Can it be prevented? Can it be treated?Blei, A. T. et al. | 2007
- 570
-
Which types of graft to use in patients with acute liver failure?:(A) Auxiliary liver transplant (B) Living donor liver transplantation (C) The whole liver (A) I prefer auxiliary liver transplantJaeck, D. / Pessaux, P. / Wolf, P. et al. | 2007
- 574
-
(B) I prefer living donor liver transplantationLee, S. G. / Ahn, C. S. / Kim, K. H. et al. | 2007
- 578
-
(C) I take the whole liver onlyEarl, T. M. / Chari, R. S. et al. | 2007
- 583
-
Endogenous opioid peptides and chronic liver disease: From bedside to benchMarzioni, M. / Svegliati Baroni, G. / Alpini, G. / Benedetti, A. et al. | 2007
- 587
-
Liver iron is a surrogate marker of severe fibrosis in chronic hepatitis CGuyader, D. / Thirouard, A. S. / Erdtmann, L. / Rakba, N. / Jacquelinet, S. / Danielou, H. / Perrin, M. / Jouanolle, A. M. / Brissot, P. / Deugnier, Y. et al. | 2007
- 596
-
High predictive value of early viral kinetics in retreatment with peginterferon and ribavirin of chronic hepatitis C patients non-responders to standard combination therapyMoucari, R. / Ripault, M. P. / Oules, V. / Martinot-Peignoux, M. / Asselah, T. / Boyer, N. / Ray, A. E. / Cazals-Hatem, D. / Vidaud, D. / Valla, D. et al. | 2007
- 605
-
Detection of auto-antibodies against cytochrome P4502E1 (CYP2E1) in chronic hepatitis CVidali, M. / Occhino, G. / Ivaldi, A. / Serino, R. / Moia, S. / Alchera, E. / Carini, R. / Rigamonti, C. / Sartori, M. / Albano, E. et al. | 2007
- 613
-
Effect of hepatitis C virus treatment in fibrosis progression rate (FPR) and time to cirrhosis (TTC) in patients co-infected with human immunodeficiency virus: A paired liver biopsy studyRodriguez-Torres, M. / Rodriguez-Orengo, J. F. / Rios-Bedoya, C. F. / Fernandez-Carbia, A. / Marxuach-Cuetara, A. M. / Lopez-Torres, A. / Jimenez-Rivera, J. et al. | 2007
- 620
-
Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis CEsmat, G. / Metwally, M. / Zalata, K. R. / Gadalla, S. / Abdel-Hamid, M. / Abouzied, A. / Shaheen, A. A. / El-Raziky, M. / Khatab, H. / El-Kafrawy, S. et al. | 2007
- 628
-
Features associated with success rate and performance of fibroscan measurements for the diagnosis of cirrhosis in HCV patients: A prospective study of 935 patientsKettaneh, A. / Marcellin, P. / Douvin, C. / Poupon, R. / Ziol, M. / Beaugrand, M. / de Ledinghen, V. et al. | 2007
- 635
-
HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administrationRosenau, J. / Kreutz, T. / Kujawa, M. / Bahr, M. J. / Rifai, K. / Hooman, N. / Finger, A. / Michel, G. / Nashan, B. / Kuse, E. R. et al. | 2007
- 645
-
Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiationKremer-Tal, S. / Narla, G. / Chen, Y. / Hod, E. / DiFeo, A. / Yea, S. / Lee, J. S. / Schwartz, M. / Thung, S. N. / Fiel, I. M. et al. | 2007
- 655
-
Differential expression of hDAB2IPA and hDAB2IPB in normal tissues and promoter methylation of hDAB2IPA in hepatocellular carcinomaQiu, G. H. / Xie, H. / Wheelhouse, N. / Harrison, D. / Chen, G. G. / Salto-Tellez, M. / Lai, P. / Ross, J. A. / Hooi, S. C. et al. | 2007
- 664
-
Expression of large tenascin-C splice variants by hepatic stellate cells/myofibroblasts in chronic hepatitis CEl-Karef, A. / Kaito, M. / Tanaka, H. / Ikeda, K. / Nishioka, T. / Fujita, N. / Inada, H. / Adachi, Y. / Kawada, N. / Nakajima, Y. et al. | 2007
- 674
-
The renin-angiotensin system in a rat model of hepatic fibrosis: Evidence for a protective role of Angiotensin-(1-7)Pereira, R. M. / dos Santos, R. A. / Teixeira, M. M. / Leite, V. H. / Costa, L. P. / da Costa Dias, F. L. / Barcelos, L. S. / Collares, G. B. / Simoes e Silva, A. C. et al. | 2007
- 682
-
P60-c-src suppresses apoptosis through inhibition of caspase 8 activation in hepatoma cells, but not in primary hepatocytesDe Toni, E. N. / Kuntzen, C. / Gerbes, A. L. / Thasler, W. E. / Sonuc, N. / Mucha, S. R. / Camaj, P. / Bruns, C. / Goke, B. / Eichhorst, S. T. et al. | 2007
- 692
-
Role of p38 map kinase in glycine-induced hepatocyte resistance to hypoxic injuryCarini, R. / Alchera, E. / Baldanzi, G. / Piranda, D. / Splendore, R. / Grazia De Cesaris, M. / Caraceni, P. / Graziani, A. / Albano, E. et al. | 2007
- 700
-
NAFLD and hyperinsulinemia are major determinants of serum ferritin levelsZelber-Sagi, S. / Nitzan-Kaluski, D. / Halpern, Z. / Oren, R. et al. | 2007
- 708
-
Identification of a gene-pathway associated with non-alcoholic steatohepatitisRubio, A. / Guruceaga, E. / Vazquez-Chantada, M. / Sandoval, J. / Martinez-Cruz, L. A. / Segura, V. / Sevilla, J. L. / Podhorski, A. / Corrales, F. J. / Torres, L. et al. | 2007
- 719
-
HBV pathogenesis in animal models: Recent advances on the role of plateletsIannacone, M. / Sitia, G. / Ruggeri, Z. M. / Guidotti, L. G. et al. | 2007
- 727
-
Abnormalities of hemostasis in chronic liver disease: Reappraisal of their clinical significance and need for clinical and laboratory researchTripodi, A. / Mannucci, P. M. et al. | 2007
- 734
-
Hepatology may have problems with putative surrogate outcome measuresGluud, C. / Brok, J. / Gong, Y. / Koretz, R. L. et al. | 2007
- 743
-
Immune-mediated hepatitis-associated aplastic anemia caused by the emergence of a mutant hepatitis B virus undetectable by standard assaysCariani, E. / Pelizzari, A. M. / Rodella, A. / Gargiulo, F. / Imberti, L. / Manca, N. / Rossi, G. et al. | 2007
- 748
-
Met-thodologyDufour, J. F. et al. | 2007
- 751
-
Non-invasive tests for liver fibrosis: Encouraging or discouraging results?Burroughs, A. K. / Cholongitas, E. et al. | 2007
- 756
-
Tailoring antiviral therapy in chronic hepatitis B patients with lamivudine resistanceBrunetto, M. R. et al. | 2007
- 759
-
HCV NS5A inhibits interferon-a signaling through suppression of STAT1 phosphorylation in hepatocyte-derived cell linesLan, K. H. / Lan, K. L. / Lee, W. P. / Sheu, M. L. / Chen, M. Y. / Lee, Y. L. / Yen, S. H. / Chang, F. Y. / Lee, S. D. et al. | 2007
- 768
-
The treatment of chronic hepatitis C with peginterferon alfa-2a (40kDa) plus ribavirin in haemodialysed patients awaiting renal transplantRendina, M. / Schena, A. / Castellaneta, N. M. / Losito, F. / Amoruso, A. C. / Stallone, G. / Schena, F. P. / Leo, A. D. / Francavilla, A. et al. | 2007
- 775
-
Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis CLeroy, V. / Hilleret, M. N. / Sturm, N. / Trocme, C. / Renversez, J. C. / Faure, P. / Morel, F. / Zarski, J. P. et al. | 2007
- 783
-
Epidemiological profile of 806 Italian children with hepatitis C virus infection over a 15-year periodBortolotti, F. / Jorio, R. / Resti, M. / Camma, C. / Marcellini, M. / Giacchino, R. / Marazzi, M. G. / Verucchi, G. / Zancan, L. / Barbera, C. et al. | 2007
- 791
-
Efficacy and safety of adefovir dipivoxil 20mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10mg dailyHezode, C. / Chevaliez, S. / Bouvier-Alias, M. / Roudot-Thoraval, F. / Brillet, R. / Zafrani, E. S. / Dhumeaux, D. / Pawlotsky, J. M. et al. | 2007
- 797
-
Bacterial translocation is downregulated by anti-TNF-a monoclonal antibody administration in rats with cirrhosis and ascitesFrances, R. / Chiva, M. / Sanchez, E. / Gonzalez-Navajas, J. M. / Llovet, T. / Zapater, P. / Soriano, G. / Munoz, C. / Balanzo, J. / Perez-Mateo, M. et al. | 2007
- 804
-
Decreased leukocyte recruitment in the mesenteric microcirculation of rats with cirrhosis is partially restored by treatment with peginterferon: An in vivo studyGeerts, A. M. / Cheung, K. J. / Vlierberghe, H. V. / De Vriese, A. S. / Mortier, S. / Vanheule, E. / Lameire, N. / De Vos, M. / Colle, I. et al. | 2007
- 816
-
Endotoxemia contributes to the immune paralysis in patients with cirrhosisLin, C. Y. / Tsai, I. F. / Ho, Y. P. / Huang, C. T. / Lin, Y. C. / Lin, C. J. / Tseng, S. C. / Lin, W. P. / Chen, W. T. / Sheen, I. S. et al. | 2007
- 827
-
Worldwide mortality from cirrhosis: An update to 2002Bosetti, C. / Levi, F. / Lucchini, F. / Zatonski, W. A. / Negri, E. / La Vecchia, C. et al. | 2007
- 840
-
Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinomaSemela, D. / Piguet, A. C. / Kolev, M. / Schmitter, K. / Hlushchuk, R. / Djonov, V. / Stoupis, C. / Dufour, J. F. et al. | 2007
- 849
-
R-Etodolac decreases b-catenin levels along with survival and proliferation of hepatoma cellsBehari, J. / Zeng, G. / Otruba, W. / Thompson, M. D. / Muller, P. / Micsenyi, A. / Sekhon, S. S. / Leoni, L. / Monga, S. P. et al. | 2007
- 858
-
High hepatic glutathione stores alleviate Fas-induced apoptosis in miceCazanave, S. / Berson, A. / Haouzi, D. / Vadrot, N. / Fau, D. / Grodet, A. / Letteron, P. / Feldmann, G. / El-Benna, J. / Fromenty, B. et al. | 2007
- 869
-
The Interleukin-1 receptor antagonist is a direct target gene of PPARa in liverStienstra, R. / Mandard, S. / Tan, N. S. / Wahli, W. / Trautwein, C. / Richardson, T. A. / Lichtenauer-Kaligis, E. / Kersten, S. / Muller, M. et al. | 2007
- 878
-
Pharmacological inhibition of the vitronectin receptor abrogates PDGF-BB-induced hepatic stellate cell migration and activation in vitroPatsenker, E. / Popov, Y. / Wiesner, M. / Goodman, S. L. / Schuppan, D. et al. | 2007
- 888
-
Hyperthyroidism induces apoptosis in rat liver through activation of death receptor-mediated pathwaysKumar, A. / Sinha, R. A. / Tiwari, M. / Singh, R. / Koji, T. / Manhas, N. / Rastogi, L. / Pal, L. / Shrivastava, A. / Sahu, R. P. et al. | 2007
- 899
-
Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitisKarlsen, T. H. / Boberg, K. M. / Olsson, M. / Sun, J. Y. / Senitzer, D. / Bergquist, A. / Schrumpf, E. / Thorsby, E. / Lie, B. A. et al. | 2007
- 907
-
Hepatic gene expression and lipid parameters in complement C3-/- mice that do not develop ethanol-induced steatosisBykov, I. / Jauhiainen, M. / Olkkonen, V. M. / Saarikoski, S. T. / Ehnholm, C. / Junnikkala, S. / Vakeva, A. / Lindros, K. O. / Meri, S. et al. | 2007
- 915
-
The phosphatidylethanolamine N-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese populationDong, H. / Wang, J. / Li, C. / Hirose, A. / Nozaki, Y. / Takahashi, M. / Ono, M. / Akisawa, N. / Iwasaki, S. / Saibara, T. et al. | 2007
- 921
-
A novel mutation in ferroportin implicated in iron overloadWallace, D. F. / Dixon, J. L. / Ramm, G. A. / Anderson, G. J. / Powell, L. W. / Subramaniam, V. N. et al. | 2007
- 927
-
Vascular endothelial dysfunction in cirrhosisIwakiri, Y. / Groszmann, R. J. et al. | 2007
- 935
-
Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndromeArroyo, V. / Terra, C. / Gines, P. et al. | 2007
- 947
-
Methodology of superiority vs. equivalence trials and non-inferiority trialsChristensen, E. et al. | 2007
- 955
-
Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategiesHemmann, S. / Graf, J. / Roderfeld, M. / Roeb, E. et al. | 2007
- 976
-
Professor Peter J. Scheuer (15 November 1928 - 1 March 2006)Desmet, V. et al. | 2007
- 978
-
Intraductal papillary mucinous tumors of both biliary and pancreatic ductsZalinski, S. / Paradis, V. / Valla, D. / Belghiti, J. et al. | 2007
- 980
-
A coffee with your brandy, Sir?Kendrick, S. F. / Day, C. P. et al. | 2007
- 983
-
Erratum to "Does treatment with interferon-based therapy improve the natural history of chronic hepatitis B infection?" [J Hepatol 46 (2007) 6-8]Lau, G. K. et al. | 2007
- 985
-
Hepatitis C virus: The viral way to fatty liverClement, S. / Negro, F. et al. | 2007
- 988
-
Ribavirin in the treatment of recurrent hepatitis C after liver transplantation: Difficult to manage but essential for successSamuel, D. / Roche, B. et al. | 2007
- 992
-
Fatigue in cholestatic liver disease: Is it all in the mind?Jones, D. E. et al. | 2007
- 995
-
Dangerous liaisons: Drug, host and the environmentAithal, G. P. et al. | 2007
- 999
-
Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: Genotype-3a core has a stronger effect than genotype-1b coreJackel-Cram, C. / Babiuk, L. A. / Liu, Q. et al. | 2007
- 1009
-
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis CAngelico, M. / Petrolati, A. / Lionetti, R. / Lenci, I. / Burra, P. / Donato, M. F. / Merli, M. / Strazzabosco, M. / Tisone, G. et al. | 2007
- 1018
-
Ethnicity, substance use, and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccinationWang, L. Y. / Lin, H. H. et al. | 2007
- 1026
-
AT1 receptor antagonist Candesartan in selected cirrhotic patients: Effect on portal pressure and liver fibrosis markersDebernardi-Venon, W. / Martini, S. / Biasi, F. / Vizio, B. / Termine, A. / Poli, G. / Brunello, F. / Alessandria, C. / Bonardi, R. / Saracco, G. et al. | 2007
- 1034
-
Bradykinesia in cirrhotic patients with early hepatic encephalopathy is related to a decreased glucose uptake of frontomesial cortical areas relevant for movement initiationGiewekemeyer, K. / Berding, G. / Ahl, B. / Ennen, J. C. / Weissenborn, K. et al. | 2007
- 1040
-
Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic ratsAbraldes, J. G. / Rodriguez-Vilarrupla, A. / Graupera, M. / Zafra, C. / Garcia-Caldero, H. / Garcia-Pagan, J. C. / Bosch, J. et al. | 2007
- 1047
-
The role of estrogen receptor subtypes in ameliorating hepatic injury following trauma-hemorrhageShimizu, T. / Yu, H. P. / Suzuki, T. / Szalay, L. / Hsieh, Y. C. / Choudhry, M. A. / Bland, K. I. / Chaudry, I. H. et al. | 2007
- 1055
-
Treatment with 2-AAF blocks the small hepatocyte-like progenitor cell response in retrorsine-exposed ratsBest, D. H. / Coleman, W. B. et al. | 2007
- 1064
-
Pro-fibrogenic potential of PDGF-D in liver fibrosisBorkham-Kamphorst, E. / van Roeyen, C. R. / Ostendorf, T. / Floege, J. / Gressner, A. M. / Weiskirchen, R. et al. | 2007
- 1075
-
In vivo altered unfolded protein response and apoptosis in livers from lipopolysaccharide-challenged cirrhotic ratsTazi, K. A. / Bieche, I. / Paradis, V. / Guichard, C. / Laurendeau, I. / Dargere, D. / Legrand, A. / Fay, M. / Pedruzzi, E. / Robin, M. A. et al. | 2007
- 1089
-
Role of insulin receptor substrate-4 in IGF-I-stimulated HEPG2 proliferationCuevas, E. P. / Escribano, O. / Chiloeches, A. / Ramirez Rubio, S. / Roman, I. D. / Fernandez-Moreno, M. D. / Guijarro, L. G. et al. | 2007
- 1099
-
Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitisvan Os, E. / van den Broek, W. W. / Mulder, P. G. / ter Borg, P. C. / Bruijn, J. A. / van Buuren, H. R. et al. | 2007
- 1104
-
Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosisTokushige, K. / Takakura, M. / Tsuchiya-Matsushita, N. / Taniai, M. / Hashimoto, E. / Shiratori, K. et al. | 2007
- 1111
-
Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatmentRosenberg, P. / Urwitz, H. / Johannesson, A. / Ros, A. M. / Lindholm, J. / Kinnman, N. / Hultcrantz, R. et al. | 2007
- 1119
-
Accumulation of proteins bearing atypical isoaspartyl residues in livers of alcohol-fed rats is prevented by betaine administration: Effects on protein-l-isoaspartyl methyltransferase activityKharbanda, K. K. / Mailliard, M. E. / Baldwin, C. R. / Sorrell, M. F. / Tuma, D. J. et al. | 2007
- 1126
-
Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and CTargher, G. / Bertolini, L. / Padovani, R. / Rodella, S. / Arcaro, G. / Day, C. et al. | 2007
- 1133
-
Pediatric nonalcoholic fatty liver disease (NAFLD): A "growing" problem?Roberts, E. A. et al. | 2007
- 1143
-
Genetics in liver diseasesPietrangelo, A. / Oude Elferink, R. / Prieto, J. / Bacon, B. R. et al. | 2007
- 1149
-
Do not trivialize the Fibroscan examination, value its accuracyRigamonti, C. / Fraquelli, M. et al. | 2007
- 1150
-
Vaptans: A promising therapy in the management of advanced cirrhosisGines, P. et al. | 2007
- I
-
Guide for Authors| 2007
- III
-
Volume Contents| 2007
- ix
-
Contents| 2007
- S9
-
[16] MECHANISMS OF HEPATITIS C VIRUS (HCV)-INDUCED HEPATIC STEATOSIS IN TRANSGENIC MICELerat, H. / Foufelle, F. / Pawlotsky, I. M. et al. | 2007
- S10
-
[19] WEEKLY ALCOHOL CONSUMPTION AND EPISODIC DRINKING ARE ASSOCIATED WITH PROGRESSION OF HEPATIC FIBROSIS IN NAFLDEkstedt, M. / Franzen, L. E. / Bendtsen, P. / Mathiesen, U. L. / Bodemar, G. / Kechagias, S. et al. | 2007
- S12
-
[24] MYCOPHENOLIC ACID TREATED MYELOID DENDRITIC CELLS EXHIBIT TOLEROGENIC PROPERTIESCicinnati, V. R. / Hou, J. / Klein, C. G. / Frilling, A. / Gerken, G. / Broelsch, C. E. / Beckebaum, S. et al. | 2007
- S13
-
[27] DIFFERENTIAL CYTOKINE PATTERN OF HDV-SPECIFIC CELLULAR IMMUNE RESPONSES DISTINGUISHES TREATMENT RESPONDER AND NONRESPONDER TO PEG-IFNa-2a TREATMENT: RESULTS FROM THE HEP-NET/INTERNATIONAL HIDIT-1 STUDYWedemeyer, H. / Ciner, A. / Yurdaydin, C. / Zachou, K. / Asian, N. / Meyer, S. / Heidrich, B. / Manns, M. P. et al. | 2007
- S16
-
[34] EXOGENOUS ADMINISTRATION OF ERYTHROPOETIN IMPROVES LIVER REGENERATION OF THE DONOR AND RECIPIENT IN A RAT LIVING RELATED LIVER TRANSPLANTATION MODELBockhorn, M. / Fingas, C. / Niehues, E. / Trippler, M. / Frilling, A. / Broelsch, C. E. / Schlaak, J. F. et al. | 2007
- S19
-
[41] ACIDIC SPHINGOMYELINASE IS REQUIRED FOR TNF-INDUCED MITOCHONDRIAL PERMEABILIZATION AND HEPATOCELLULAR DEATH VIA CARDIOLIPIN PEROXIDATIONMari, M. / Colell, A. / Garcia-Ruiz, C. / Fernandez-Checa, J. C. et al. | 2007
- S24
-
[51] SINUSOIDAL REMODELING: A NOVEL THERAPEUTIC APPROACH TO TREAT PORTAL HYPERTENSIONSemela, D. / Das, A. / Langer, D. A. / Kang, N. / Hendrickson, H. / Shah, V. et al. | 2007
- S25
-
[53] VIROLOGICAL AND BIOCHEMICAL RESPONSE IN PATIENTS WITH HBeAg-NEGATIVE CHB TREATED WITH PEGINTERFERON a-2a (40 kD) +- LAMIVUDINE: 3-YEAR FOLLOW-UP RESULTSMarcellin, P. / Bonino, F. / Lau, O. K. / Farci, P. / Yurdaydin, C. / Piratvisuth, T. / Luo, K. / Gurel, S. / Hadziyannis, S. / Wang, Y. et al. | 2007
- S26
-
[56] HBV RTI233V POLYMERASE VARIANT REMAINS SENSITIVE TO ADEFOVIRCurtis, M. / Zhu, Y. / Borroto-Esoda, K. et al. | 2007
- S28
-
[61] LOWER VIRAL PRODUCTION IN HBeAg-NEGATIVE PATIENTS IS DUE TO BOTH REDUCED POOL SIZE AND ACTIVITY OF THE HBV cecDNAWachtler, P. / Volz, T. / Lutgehetmann, M. / Wursthorn, K. / Petersen, J. / Dandri, M. et al. | 2007
- S29
-
[64] INFECTION AND REPLICATION OF NATURALLY OCCURRING HEPATITIS C VIRUS GENOTYPE 1, 2, 3 AND 4 IN NORMAL HUMAN HEPATOCYTE CULTURESBuck, M. / Chojkier, M. et al. | 2007
- S30
-
[67] STRUCTURAL AND GENETIC VARIABILITY OF THE RNA-DEPENDENT RNA POLYMERASE, NSB, FROM HEPATITIS C VIRUS (HCV)Simister, P. C. / Brillet, R. / Pawlotsky, J. M. / Bressanelli, S. et al. | 2007
- S32
-
[72] THE RAS INHIBITOR FTS EXERTS ITS ANTI-TUMOUR EFFECT IN THE DEN MODEL OF HEPATOCARCINOGENESIS TROUGH INDUCTION OF TUMOUR CELL APOPTOSIS AND COMPENSATORY PROLIFERATION NON-TUMOUR CELLSSchneider-Merck, T. / Borbath, I. / De Saeger, C. / Leclercq, I. / Horsmans, Y. / Starkel, P. et al. | 2007
- S33
-
[75] SFRP1 AND SFRP5, TWO NEWLY IDENTIFIED TUMOR SUPPRESSORS IN HUMAN HEPATOCELLULAR CARCINOMA?Lavergne, E. / Quelard, D. / Hendaoui, I. / Clement, B. / Musso, O. et al. | 2007
- S34
-
[78] COMPARISON BETWEEN HEPATIC VENOUS PRESSURE GRADIENT (HVPG) AND LIVER STIFFNESS MEASUREMENT (LSM) IN PATIENTS WITH HCV-RELATED FIBROSIS/CIRRHOSISVizzutti, F. / Arena, U. / Romanelli, R. G. / Rega, L. / Petrarca, A. / Moscarella, S. / Marra, F. / Laffi, G. / Pinzani, M. et al. | 2007
- S35
-
[80] THE IMPACT OF EPISODES OF HEPATIC ENCEPHALOPATHY (HE) ON NEUROCOGNITIVE FUNCTION AFTER LIVER TRANSPLANTATIONSotil, E. U. / Gottstein, J. / Randolph, C. / Blei, A. T. et al. | 2007
- S36
-
[83] TREATMENT OF BUDD CHIARI SYNDROME WITH TIPS. LONG-TERM RESULTS IN 124 PATIENTS AND EVALUATION OF PROGNOSTIC FACTORSRaffa, S. / Heydtmann, M. / Plessier, A. / Darwish Murad, S. / Fabris, F. / Vizzini, G. / Abraldes, J. G. / Bellot, P. / Luca, A. / Primignani, M. et al. | 2007
- S39
-
[87] EFFICACY OF ANTIVIRAL THERAPY ON DISEASE PROGRESSION IN HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: A RANDOMIZED CONTROLLED STUDYCarrion, J. A. / Navasa, M. / Garcia-Retortillo, M. / Garcia-Pagan, J. C. / Crespo, G. / Bruguera, M. / Bosch, J. / Forns, X. et al. | 2007
- S41
-
[92] VIRAL SEQUENCE EVOLUTION IN ACUTE HCV INFECTIONKuntzen, T. / Timm, J. / Berical, A. / Lewis, L. / Tones, A. / Schulze zur Wiesch, J. / Li, B. / Chung, R. T. / Lauer, G. M. et al. | 2007
- S42
-
[95] RESTORATION OF CD AND CDS EXHAUSTION BY ANTI-PD-L IN ACUTE HCV INFECTION: A COMPLEMENTARY APPROACH FOR THERAPY?Urbani, S. / Amadei, B. / Pedrazzi, G. / Tola, D. / Cavallo, M. C. / Missale, G. / Ferrari, C. et al. | 2007
- S43
-
[98] EFFECTOR/MEMORY SUBSETS AND FUNCTIONALITY OF CD4/CD8+ T-CELLS DURING POTENT ANTIVIRAL THERAPY IN CHRONIC HEPATITIS B (CHB)Riva, A. / Cooksley, H. / Hou, J. / Vitek, L. / Urbanek, P. / Wedemeyer, H. / Manns, M. / Abbott, W. / Gane, E. / Hofmann, P. et al. | 2007
- S44
-
[100] INHERITED VARIANTS OF GENES INVOLVED IN INSULIN SIGNALING AND LIPOGENESIS INFLUENCE THE RISK OF HEPATIC FIBROSIS IN NONALCOHOLIC FATTY LIVER DISEASEDongiovanni, P. / Valenti, L. / Rametta, R. / Fracanzani, A. L. / Fargion, S. et al. | 2007
- S46
-
[105] ARTERIAL AND PERIBILIARY VASCULOGENESIS DURING LIVER DEVELOPMENT IS MODULATED BY ANGIOGENIC GROWTH FACTORS EXPRESSED BY DUCTAL PLATE CELLS AND HEPATOBLASTSFabris, L. / Cadamuro, M. / Libbrecht, L. / Spirli, C. / Fiorotto, R. / Okolicsanyi, L. / Roskams, T. / Strazzabosco, M. et al. | 2007
- S47
-
[108] LARGE POPULATION STUDY ON THE NATURAL HISTORY OF SPONTANEOUS HEPATITIS B E-ANTIGEN SEROCONVERSION: RISK OF HEPATOCELLULAR CARCINOMAFung, J. / Lai, C. L. / Wong, O. K. / Yuen, M. F. et al. | 2007
- S48
-
[110] THE SPECTRUM OF AUTOIMMUNE CHOLANGITIS IN CHILDHOODSciveres, M. / Maggiore, G. / Giurici, N. / Ventura, A. / Bernard, O. et al. | 2007
- S49
-
[113] PROGRESSIVE FIBROSIS IN NON-ALCOHOLIC STEATOHEPATITIS - ASSOCIATION WITH ALTERED REGENERATION AND A DUCTULAR REACTIONRichardson, M. M. / Jonsson, T. R. / Powell, E. E. / Brunt, E. M. / Neuschwander-Tetri, B. A. / Bhathal, P. S. / Dixon, J. B. / Weltman, M. D. / Tilg, H. / Moschen, A. R. et al. | 2007
- S51
-
[118] EXTRACELLULAR SUPEROXIDE DISMUTASE GENE TRANSFER REDUCES PORTAL PRESSURE AND IMPROVES INTRAHEPATIC ENDOTHELIAL DYSFUNCTION IN CIRRHOTIC RAT LIVERS BY DIMINISHING SUPEROXIDE AND INCREASING NITRIC OXIDE BIOAVAILABILITYLavina, B. / Gracia-Sancho, J. / Rodriguez-Vilarrupla, A. / Chu, Y. / Heistad, D. D. / Bosch, J. / Garcia-Pagan, J. C. et al. | 2007
- S52
-
[121] IN EXPERIMENTAL PREASCITIC LIVER CIRRHOSIS CALCIUM-DEPENDENT DIURETIC SYSTEMS ARE DOWNREGULATED, BUT MAY BE NORMALIZED BY SPECIFIC METABOLIC AND PHARMACOLOGIC STIMULISansoe, G. / Aragno, M. / Wong, F. / Rosina, F. / Smedile, A. / Rizzetto, M. et al. | 2007
- S56
-
[127] Phil PROOF OF CONCEPT STUDY OF CELGOSIVIR IN COMBINATION WITH PEGINTERFERON o-2b AND RIBAVIRIN IN CHRONIC HEPATITIS C GENOTYPE-1 NON-RESPONDER PATIENTSKaita, K. / Yoshida, E. / Kunimoto, D. / Anderson, F. / Morris, S. / Marotta, P. / Scully, L. / Peltekian, K. / Enns, R. / Diaz-Mitoma, F. et al. | 2007
- S60
-
[133] PERSISTENT EXPRESSION OF MESENCHYMAL MARKERS AFTER HEPATOCYTE DIFFERENTIATION OF HUMAN BONE MARROW MESENCHYMAL STEM CELLSLysy, P. / Najimi, M. / Campard, D. / Smets, F. / Soka, E. M. et al. | 2007
- S62
-
[138] LACTATE ALONE IS NOT AN ACCURATE PREDICTOR OF POOR PROGNOSIS IN PARACETAMOL INDUCED FULMINANT LIVER FAILUREBates, C. M. / Kochar, N. / Davidson, J. S. / Hayes, P. C. / Simpson, K. J. et al. | 2007
- S63
-
[141] LONG TERM FOLLOW-UP OF LIVER TRANSPLANTATION (OLT) FOR CHOLESTATIC AND AUTOIMMUNE END STAGE LIVER DISEASESBlasone, L. / Fagiuoli, S. / Colledan, M. / Strazzabosco, M. / Lenzi, M. / Floreani, A. / Burra, P. / Cillo, U. / Merenda, R. / Donato, M. F. et al. | 2007
- S64
-
[144] IDENTIFICATION OF ANTI-PARIETAL CELL AUTOANTIBODIES (PCA) AS SEROLOGICAL MARKER OF RECURRENT PRIMARY BILIARY CIRRHOSIS AFTER LIVER TRANSPLANTATIONCiesek, S. / Becker, T. / Klempnauer, J. / Manns, M. P. / Strassburg, C. P. et al. | 2007
- S65
-
[147] DE NOVO AUTOIMMUNE HEPATITIS FOLLOWING LIVER TRANSPLANTATION IN ADULTS: WHAT LIES BEHINDDazzani, F. / Gramenzi, A. / Biselli, M. / Vitale, G. / Vukotic, R. / Cursaro, C. / Lorenzini, S. / Bernardi, M. / Andreone, P. et al. | 2007
- S66
-
[150] CADAVERIC WHOLE LIVER TRANSPLANTATION FOR NON-ACETAMINOPHEN FULMINANT HEPATIC FAILURE: A 20-YEAR EXPERIENCEDetry, O. / De Roover, A. / Coimbra, C. / Squifflet, J. P. / Delwaide, J. / Kaba, A. / Joris, J. / Hans, M. F. / Delbouille, M. H. / Monnard, J. et al. | 2007
- S70
-
[161] HEPATITIS E VIRUS INFECTION CAN EVOLVE TO CHRONIC HEPATITIS IN ORGAN-TRANSPLANT PATIENTSKamar, N. / Peron, J. M. / Ouezzani, L. / Mansuy, J. M. / Selves, J. / Guitard, J. / Cointault, O. / Bureau, C. / Durand, D. / Vinel, J. P. et al. | 2007
- S71
-
[164] CHRONIC RENAL FAILURE POST LIVER TRANSPLANT; PREVALENCE AND RATE OF DECLINELeithead, J. A. / Ferguson, J. W. / Hayes, P. C. et al. | 2007
- S72
-
[167] LONG TERM EFFICACY OF ENDOSCOPIC TREATMENT OF BILIARY COMPLICATIONS (BC) AFTER ORTHOTOPIC LIVER TRANSPLANTATION (OLT)Mejdoubi, S. / Chermak, F. / Payen, J. E. / Bauret, P. / Bregeon, C. / Railhac, N. / Muscari, F. / Sue, B. / Kamar, N. / Rostaing, L. et al. | 2007
- S73
-
[170] PREVALENCE OF HYPERDYNAMIC CIRCULATION AND PORTOPULMONARY HYPERTENSION IN PATIENTS UNDERGOING LIVER TRANSPLANT EVALUATIONPellicelli, A. M. / Villani, R. / Struglia, C. / Nauri, L. / DAmbrosio, C. / Fondacaro, L. / Guarascio, P. / Barbara, G. / Paffetti, A. / Romano, M. et al. | 2007
- S74
-
[173] SYSTEMATIC APPLICATION OF CADAVER EXPANDED DONOR CRITERIA AND LIVING DONOR LIVER ALLOGRAFTS IMPROVE PATIENT ACCESS AND OUTCOMESRenz, J. F. / Lo, I. T. / Alkofer, B. / Kin, C. / Guarrera, J. V. / Samstein, B. / Bellemare, S. / Jan, D. / Kinkhabwala, M. / Emond, J. C. et al. | 2007
- S75
-
[176] INCIDENCE AND PREDICTIVE FACTORS OF INFECTION DURING MARS THERAPYSanz-Garcia, C. / Catalina, M. V. / Gomez-Camarero, J. / Rincon, D. / Salcedo, M. / Lo lacono, O. / Clemente, G. / Banares, R. et al. | 2007
- S76
-
[178] TRANSJUGULAR LIVER BIOPSY: ARE 4 CORES BETTER THAN 3 AND DOES A CASSETTE PREVENT FRAGMENTATIONShusang, V. / Marelli, L. / Cholongitas, E. / Kalambokis, G. / Manousou, E. / Senzolo, M. / Patch, D. / Burroughs, A. K. et al. | 2007
- S77
-
[181] MEASURING ACTUAL LIVER FUNCTION BY THE NEW INTRAVENOUS UMAX-TEST (MAXIMAL ENZYMATIC LIVER FUNCTION CAPACITY BASED ON 13C-METHACETIN KINETICS) BEFORE AND AFTER LIVER RESECTIONStockmann, M. / Riecke, B. / Fricke, M. / Niehues, S. / Lemke, A. R. / Neuhaus, P. et al. | 2007
- S79
-
[187] PORTAL HYPERTENSION CONTRIBUTES TO SPATIAL REFERENCE MEMORY DEFICIT IN THE RATAller, M. A. / Mendez, M. / Mendez-Lopez, M. / Sanchez-Patan, F. / Lopez, L. / Anchuelo, R. / Mejia, I. / Arias, J. / Arias, J. L. et al. | 2007
- S80
-
[190] INHIBITION OF ADRENERGIC TRANSMISSION MAY CONTRIBUTE TO SPLANCHNIC VASODILATION IN PORTAL HYPERTENSIONColl, M. / Genesca, J. / Otero, T. / Rodriguez, A. / Garcia Pagan, J. C. / Oria, M. / Bosch, J. / Martell, M. et al. | 2007
- S82
-
[196] EXPERIMENTAL ORTHOTOPIC HCC GROWTH IS ACCELERATED IN HEPATIC FIBROSISKornek, M. / Raskopf, E. / Tolba, R. / Sauerbruch, T. et al. | 2007
- S83
-
[199] VASCULAR ENDOTHELIAL GROWTH FACTOR TYPE A (VEGF-A) AND ANGIOPOIETIN-2 (ANG-2) ARE RELEVANT IN THE PATHOGENESIS OF THE INCREASED VASCULAR PERMEABILITY IN CIRRHOSISMelgar-Lesmes, P. / Tugues, S. / Morales-Ruiz, M. / Ros, J. / Fernandez-Varo, G. / Arroyo, V. / Rodes, J. / Jimenez, W. et al. | 2007
- S84
-
[202] SELECTIVE LONG-TERM ACTIVATION OF CANNABINOID CB RECEPTORS REDUCES HEPATIC FIBROSIS IN CIRRHOTIC RATS WITH ASCITESMunyoz-Luque, J. / Ros, J. / Fernandez-Varo, G. / Tugues, S. / Morales-Ruiz, M. / Alvarez, C. L. / Friedman, S. L. / Jimenez, W. et al. | 2007
- S85
-
[205] INHIBITION OF ANGIOGENESIS IN VIVO BY ALPHA(V)BETA(3) INTEGRIN ANTAGONIST EMD121974 AGGRAVATES BILIARY FIBROSIS IN RATSPatsenker, E. / Popov, Y. / Stickel, F. / Niedobitek, G. / Schuppan, D. et al. | 2007
- S86
-
[208] CLEARANCE AND METABOLISM OF 13N-AMMONIA IN CIRRHOSIS PATIENTS WITH OR WITHOUT HEPATIC ENCEPHALOPATHY AND IN HEALTHY CONTROLSSrensen, M. / Bender, D. / Keiding, S. et al. | 2007
- S88
-
[213] LIPOPOLYSACCHARIDE EXACERBATES BRAIN EDEMA AND PRODUCES COMA IN CIRRHOTIC RATS THROUGH A CYTOTOXIC MECHANISM: AN ELECTRON-MICROSCOPIC STUDYWright, G. / Davies, N. A. / Davies, D. C. / Brooks, H. F. / Shawcross, D. L. / Hodges, S. J. / Jalan, R. et al. | 2007
- S89
-
[216] MIDODRINE IN THE PREVENTION OF HEPATORENAL SYNDROME TYPE 2 RECURRENCE: A CASE-CONTROL STUDYAlessandria, C. / Debernardi-Venon, W. / Todros, L. / Rizzetto, M. / Marzano, A. et al. | 2007
- S90
-
[219] NATURAL HISTORY OF SPONTANEOUS BACTERIAL PERITONITIS: A LONGITUDINAL STUDY IN 263 CIRRHOTIC PATIENTS AFTER THE FIRST ASCITES DECOMPENSATIONCanete, N. / Erice, E. / Bargallo, A. / Cirera, I. / Masnou, H. / Miquel, M. / Coll, S. / Gimenez, M. D. / Galeras, J. A. / Morillas, R. M. et al. | 2007
- S91
-
[222] RISK OF LIVER CIRRHOSIS ASSOCIATED WITH GENOTYPE AND MUTANTS OF HEPATITIS B VIRUSChen, Y. L. / Chen, P. J. / Yang, H. I. / Iloeje, U. H. / Su, J. / Jen, C. / Yeh, S. H. / Lu, S. N. / You, S. L. / Chen, C. J. et al. | 2007
- S92
-
[225] ARGON PLASMA COAGULATION FOLLOWING ENDOSCOPIC INJECTION SCLEROTHERAPY FOR THE PREVENTION OF ESOPHAGEAL VARICEAL RECURRENCE AND REBLEEDINGEl-Saadany, M. / El-Meneesy, A. / Hamed, M. et al. | 2007
- S93
-
[228] SYSTEMIC HYPERKINETIC STATE: AN INDEPENDENT PREDICTIVE MARKER OF EARLY MORTALITY IN CIRRHOTIC PATIENTS NOT RECEIVING BETA-BLOCKERSFrancoz, C. / Moreau, R. / Sobesky, R. / Paugam-Burtz, C. / Lebrec, D. / Belghiti, J. / Valla, D. / Durand, F. et al. | 2007
- S95
-
[233] GALACTOSE ELIMINATION CAPACITY IS A PREDICTOR OF SURVIVAL TIME IN PATIENTS WITH CIRRHOSIS OF THE LIVERJepsen, P. / Vilstrup, H. / Sorensen, H. T. / Ott, P. / Keiding, S. / Andersen, P. K. / Tygstrup, N. et al. | 2007
- S96
-
[236] ACUTE HVPG RESPONSE TO I. V. PROPRANOLOL AND RISK OF PORTAL HYPERTENSION RELATED BLEEDINGLa Mura, V. / Abraldes, J. G. / Retto, O. / Bellot, P. / Raffa, S. / Garcia-Pagan, J. C. / Bosch, J. et al. | 2007
- S98
-
[242] IRON OVERLOAD AND INCIDENCE OF SPONTANEOUS BACTERIAL PERITONITIS IN CIRRHOTIC PATIENTS WITH ASCITESPardo, A. / Ortega, J. / Quintero, E. et al. | 2007
- S99
-
[245] HEPATIC VENOUS PRESSURE GRADIENT (HVPG) PREDICTS THE FIRST CLINICAL DECOMPENSATION IN PATIENTS WITH CHRONIC HEPATITIS C (CHC)-RELATED CIRRHOSISRincon, D. / Lo lacono, O. / Hernando, A. / Gomez, J. / Salcedo, M. / Catalina, M. V. / Sanz, C. / Clemente, G. / Matilla, A. / Nunez, O. et al. | 2007
- S100
-
[248] HCC-RISK AFTER TIPS-IMPLANTATION: BARE STENTS VERSUS PTFE COVERED STENTSUlbrich, G. / Angermayr, B. / Karnel, F. / Kochl, A. / Schmook, M. / Cejna, M. / Peck-Radosavljevic, M. et al. | 2007
- S101
-
[251] EFFECTS OF PROLONGED ADMINISTRATION OF MIDODRINE IN THE TREATMENT OF DIURETIC-RESISTANT ASCITIS: A PILOT STUDYZanditenas, D. / Condat, B. / Blazquez, M. / Bonnet, J. / Mavier, J. P. / Mallat, A. / Duvoux, C. et al. | 2007
- S102
-
[253] SINGLE AND MULTIPLE HEPATOCELLULAR ADENOMA: A SINGLE CENTRE SURGICAL EXPERIENCE OF 120 CASESBelghiti, J. / Dokmak, S. / Paradis, V. / Vilgrain, V. / Farges, O. / Sauvanet, A. / Valla, D. / Lesurte, M. / Bedossa, P. et al. | 2007
- S104
-
[258] RISK OF HEPATOCELLULAR CARCINOMA IS REDUCED BY NUMBER OF FULL-TERM PREGNANCIES: A NATIONAL FOLLOW-UP STUDY IN TAIWANFwu, C. W. / Chien, Y. C. / Kuo, H. S. / Chen, C. T. et al. | 2007
- S105
-
[261] LY2109761 INHIBITS HCC INVASION. A PRECLINICAL STUDYGiannelli, G. / Fransvea, E. / Zaccaro, B. / Picca, A. / Bergamini, C. / Antonaci, S. et al. | 2007
- S106
-
[265] IMPROVED SURVIVAL OF PATIENTS WITH HEPATOCELLULAR CARCINOMA DETECTED BY RECENT INTENSIVE SURVEILLANCEKim, D. Y. / Han, K. H. / Aim, S. H. / Lee, H. W. / Yoon, Y. J. / Kim, J. K. / Paik, Y. H. / Lee, K. S. / Chon, C. Y. / Moon, Y. M. et al. | 2007
- S107
-
[268] RESECTION VS RADIOFREQUENCY ABLATION FOR HCC FROM 3 TO 5cm: A SINGLE CENTRE EXPERIENCE ON 101 CHILD-PUGH CLASS A-B NAIVE PATIENTSLupo, L. / Panzera, P. / Carbotta, G. / Gentile, A. / Gallerani, A. / Stefano, M. / Memeo, V. et al. | 2007
- S108
-
[271] CONTRIBUTION OF THE VASCULAR PROFILE ANALYSIS AND HISTOLOGICAL PATTERNS TO THE DIFFERENTIAL DIAGNOSIS OF HEPATIC NODULESNascimento, C. / Caroli-Bottino, A. / Maia, J. / Pannain, V. et al. | 2007
- S110
-
[276] CHM-1, A NOVEL SYNTHETIC QUINOLONE WITH POTENT AND SELECTIVE ANTITUMOR ACTIVITY AGAINST HUMAN HEPATOCELLULAR CARCINOMAWang, S. W. / Kuo, S. C. / Lee, K. H. / Teng, C. M. et al. | 2007
- S112
-
[281] ADIPONECTIN ATTENUATES CD95/FAS EXPRESSION AND APOPTOSIS IN HUMAN HepG2 HEPATOMA CELLS: IMPLICATIONS FOR TREATING FATTY LIVER DISEASESMarquitan, G. / Bechmann, L. / Katsounas, A. / Schlattjan, M. / Odenthal, M. / Gerken, G. / Canbay, A. et al. | 2007
- S113
-
[284] ADENOSINE AND INTERFERON ALPHA SYNERGISTICALLY INCREASE INTERFERON GAMMA PRODUCTION OF PBMC VIA THE A3-RECEPTORJeffe, F. / Cornberg, M. / Brolsch, F. / Manns, M. P. / Wedemeyer, H. et al. | 2007
- S114
-
[287] INDUCTION OF THE INTRINSIC APOPTOSIS PATHWAY BY TNP-470 IN AN IN VIVO MODEL OF HEPATOCARCINOMAMauriz, J. L. / Gonzalez, P. / Duran, M. C. / Martin-Renedo, J. / Barrio, J. P. / Culebras, J. M. et al. | 2007
- S115
-
[290] URSODEOXYCHOLIC ACID REDUCES BILE ACID-INDUCED HEPATOCYTE APOPTOSIS BY MODULATION OF AP-1Rust, C. / Vennegeerts, T. / Beuers, U. et al. | 2007
- S116
-
[293] INTERFERON-GAMMA AUGMENTS CHEMICALLY INDUCED APOPTOSIS IN PRIMARY HEPATOCYTES BY INDUCING p53 ACCUMULATIONSchrader, J. / Liith, S. / Zander, S. / Lohse, A. W. et al. | 2007
- S120
-
[305] PERIPORTAL DOWNREGULATION OF Bsep AND Mrp2 IN EXPERIMENTAL OBSTRUCTIVE CHOLESTASIS IS MEDIATED BY TNF-ALPHA AND IL1-BETA AND IS ASSOCIATED WITH PERIPORTAL INFLAMMATION AND CYTOKINE SECRETIONDonner, M. G. / Schumacher, S. / Warskulat, U. / Heinemann, J. / Haeussinger, D. et al. | 2007
- S121
-
[308] PROTECTION AGAINST PHALLOIDIN HEPATOTOXICITY USING A SEMISYNTHETIC CHOLIC ACID DERIVATIVE, BALU-1Herraez, E. / Macias, R. I. / Vazquez-Tato, J. / Hierro, C. / Blazquez, A. G. / Martinez-Becerra, P. / Jimenez, F. / Gonzalez-San Martin, F. / Marin, J. J. et al. | 2007
- S122
-
[311] URSODEOXYCHOLIC ACID, BUT NOT NORURSODEOXYCHOLIC ACID REVERSES TAUROLITHOCHOLIC ACID-INDUCED CHOLESTASIS IN RAT LIVERMaitz, S. / Denk, G. U. / Wimmer, R. / Invernizzi, P. / Hofmann, A. F. / Beuers, U. et al. | 2007
- S123
-
[313] MECHANISMS OF HUMAN HEPATOBILIARY TRANSPORTER GENE REGULATION IN THE HEPATOCYTE-LIKE CELL LINE HepaRGMartin, I. V. / Voigt, S. / Strauch, S. / Trautwein, C. / Geier, A. et al. | 2007
- S124
-
[316] ENDOGENOUS OPIOIDS MODULATE HEPATOCYTES APOPTOSIS IN RAT MODEL OF CHRONIC CHOLESTASIS: THE ROLE OF OXIDATIVE STRESSPayabvash, S. / Kiumehr, S. / Ghazinezami, B. / Zandieh, A. / Anvari, P. / Tavangar, S. M. / Dehpour, A. R. et al. | 2007
- S126
-
[321] ACTIVATION OF COMPLEMENT AND COAGULATION PATHWAYS IS THE POTENTIAL CULPRIT CAUSING INFLAMMATION AND FIBROSIS IN HEPATIC STEATOSIS: A STUDY IN CONDITIONALLY HCV CORE TRANSGENIC MICEChang, M. L. / Yeh, C. T. / Chiu, C. T. / Lin, D. Y. / Liaw, Y. F. et al. | 2007
- S127
-
[324] ABOLISHED ACUTE PHASE RESPONSE AND ENHANCED LIVER INJURY AFTER BILE-DUCT LIGATION IN HEPATOCYTE SPECIFIC CONDITIONAL c-Met KNOCKOUT MICEGiebeler, A. / Klein, C. / Erschfeld, S. / Borowiak, M. / Birchmeier, C. / Trautwein, C. / Streetz, K. et al. | 2007
- S129
-
[329] DAMAGED ERYTHROCYTES MAY BE ASSOCIATED WITH OXIDATIVE STRESS AND FIBROGENSIS IN A RABBIT MODEL OF STEATOHEPATITISKawada, N. / Otogawa, K. / Ikeda, K. / Ikura, Y. / Ueda, M. et al. | 2007
- S132
-
[338] ANTIFIBROTIC EFFECTS OF LINDERA OBTUSILOBA EXTRACTS: DOWNREGULATION OF TGF-p INDUCED COLLAGEN TYPE I EXPRESSION AND NEUTRALIZATION OF PEROXIDE INDUCED ROS PRODUCTION IN HEPATIC STELLATE CELLSRuehl, M. / Erben, U. / Eckert, A. / Kienast, T. / Kim, K. / Yang, S. / Dagdelen, T. / Neumann, U. / Zeitz, M. / Stickel, F. et al. | 2007
- S133
-
[341] INHIBITION OF BETA-ADRENORECEPTORS RESULTS IN DELAYED FIBROSIS IN Abcb4 KNOCKOUT MICEStrack, I. / Petmecky, K. / Scheffler, M. / Schulte, S. / Lammert, F. / Varnholt, H. / Dienes, H. P. / Odenthal, M. et al. | 2007
- S136
-
[349] DIFFERENTIAL EFFECTS OF CONTROLLED PREOPERATIVE HEPATIC INFLAMMATORY RESPONSE ON LIVER REGENERATION AFTER PARTIAL HEPATECTOMYAnanian, P. / Gregoire, E. / Liprandi, A. / Berda-Haddad, Y. / Monserrat, C. / Hardwigsen, J. / Campan, P. / Le Treut, Y. P. / Gerolami, R. et al. | 2007
- S137
-
[352] EPITHELIAL- MESENCHYMAL TRANSITION IN HUMAN HEPATOCELLULAR CARCINOMA CELLS UNDER HYPOXIA: A BETA-CATENIN AND SNAIL-MEDIATED EVENT FAVOURING MIGRATION AND/OR INVASIVENESSCannito, S. / Novo, E. / Cravanzola, C. / Zamara, E. / Compagnone, A. / Valfre di Bonzo, L. / Bandino, A. / Colombatto, S. / Parola, M. et al. | 2007
- S138
-
[355] HEPATOPROTECTION DURING LIVER REGENERATION IS TRIGGERED BY IL-6-GP130-STAT3 SIGNALLING IN HEPATOCYTESDierssen, U. / Beraza, N. / Liedtke, C. / Ernst, M. / Trautwein, C. et al. | 2007
- S140
-
[360] INHIBITION OF MULTIPLE MATRIX METALLOPROTEINASE EXPRESSION BY VITAMIN K2 THROUGH PROTEIN KINASE C PATHWAY IN HUMAN HEPATOCELLULAR CARCINOMA CELLSIde, Y. / Zhang, H. / Mizuta, T. / Eguchi, Y. / Yasutake, T. / Hisatomi, A. / Ozaki, I. et al. | 2007
- S141
-
[363] A HEPATIC STEM CELL NICHE FORMS DURING LIVER INJURY: ITS CELLULAR COMPOSITION AND ORIGINLorenzini, S. / Bird, T. G. / Caldwell, H. / Vig, P. / Andreone, P. / Iridale, J. P. / Alison, M. R. / Forbes, S. J. et al. | 2007
- S142
-
[366] ADENOSINE CAN ACCELERATE THE CELL CYCLE DURING RAT LIVER REGENERATION INDUCED BY PARTIAL HEPATECTOMYMendieta-Condado, E. / Chagoya de Sanchez, V. / Hernandez-Munoz, R. et al. | 2007
- S143
-
[369] THE DUAL EGF-A/EGF-RECEPTOR TYROSINE KINASE INHIBITOR AEE-788 INHIBITS GROWTH OF HUMAN HEPATOCELLULAR CARCINOMA XENOGRAFTS IN MICEOcker, M. / Okamoto, K. / Neureiter, D. / Kaufmann, B. / Haus, U. / Herold, C. et al. | 2007
- S144
-
[372] ALPHA-LIPOIC ACID ENHANCES CHOLINE DEFICIENT DIET-INDUCED FATTY LIVER AND STEATOHEPATITIS, AND PROMOTES THE GROWTH OF PRENEOPLASTIC LESIONS IN RAT LIVERPerra, A. / Simbula, G. / Pibiri, M. / Sulas, P. / Ledda-Columbano, G. M. / Columbano, A. et al. | 2007
- S145
-
[375] INDUCTION OF STAT3 MIGHT CONTRIBUTE TO TUMOUR DEVELOPMENT IN CHEMICALLY-INDUCED HEPATOCARCINOMAS IN RATSStarkel, P. / De Saeger, C. / Leclercq, I. / Horsmans, Y. et al. | 2007
- S146
-
[378] IRON STATUS MODULATES THE EXPRESSION OF THE UBIQUITIN LIGASE MDM-2 AND ITS TARGET p53 IN MOUSE HEPATOCYTES AND HUMAN MONOCYTES; EFFECT ON THE ANTI-OXIDANT RESPONSEValenti, L. / Dongiovanni, P. / Megazzini, C. / Fracanzani, A. L. / Fargion, S. et al. | 2007
- S147
-
[380] RADIOFREQUENCY THERMAL ABLATION OF HEPATOCELLULAR CARCINOMA MAY ACTIVATE REGULATORY T CELLS BLOCKING ANTI-TUMOR T-CELL RESPONSESZerbini, A. / Pilli, M. / Pelosi, G. / Menozzi, G. / Laccabue, D. / Cerioni, S. / Pizzi, M. G. / Schivazappa, S. / Fagnoni, F. / Ferrari, C. et al. | 2007
- S148
-
[383] INTRAHEPATIC INJECTION OF ADENOVIRUS REDUCES INFLAMMATION AND INCREASES GENE TRANSFER AND THERAPEUTIC EFFECT IN MICECrettaz, J. / Berraondo, P. / Mauleon, I. / Ochoa, L. / Shankar, V. / Barajas, M. / van Rooijen, N. / Kochanek, S. / Qian, C. / Prieto, J. et al. | 2007
- S149
-
[387] INTRATUMORAL TREATMENT OF PRE-ESTABLISHED SUBCUTANEOUS HEPATOCELLULAR TUMORS WITH TUMOR LYSATE PUSED DENDRITIC CELLS ENGINEERED TO EXPRESS CD40L CONFERS HIGHER ANTITUMOR IMMUNITY THAN SUBCUTANEOUS OR INTRAVENOUS TREATMENTGonzalez-Carmona, M. A. / Timmerman, A. / Raskopf, E. / Kornek, M. / Schmidt-Wolf, I. G. / Caselmann, W. H. / Sauerbruch, T. / Schmitz, V. et al. | 2007
- S150
-
[390] WHAT IS THE HEMATOLOGICAL POTENTIAL OF ADULT NON HUMAN PRIMATE HEPATIC CELLS?Mayol, J. F. / Drouet, M. / Delaunay, C. / Mourcin, F. / Garrigou, P. / Grenier, N. / Letoublon, C. / Norol, F. / Zarski, I. P. / Herodin, F. et al. | 2007
- S151
-
[393] ANTITUMORAL EFFICACY OF SEMLIKI FOREST VIRUS VECTORS EXPRESSING IL-12 IN TUMOR MODELS IMPLANTED IN THE LIVERRodriguez-Madoz, J. R. / Guan, M. / Casales, E. / Qian, C. / Prieto, J. / Smerdou, C. et al. | 2007
- S152
-
[396] EXPRESSION OF ANTIGEN PROCESSING-PRESENTATION GENES AND CYTOKINE LEVELS IN IMMUNOTOLERANT PATIENTS WITH CHRONIC HBV INFECTIONBaweja, S. / Pati, N. T. / Hissar, S. S. / Sarin, S. K. et al. | 2007
- S153
-
[399] IMPAIRMENT OF MEMORY/EFFECTOR CELLS MATURATION MAY ACCOUNT FOR LACK OF VIRUS IMMUNE CONTROL IN PAEDIATRIC PATIENTS WITH HBV INFECTIONCarey, I. / Giannattasio, A. / Bansal, S. / Longhi, M. S. / Meda, F. / Ma, Y. / Mieli-Vergani, G. / Vergani, D. et al. | 2007
- S157
-
[409] REPEATED EXPOSURE TO SMALL DOSES OF HEPADNAVIRUS DOES NOT INDUCE HEPATITIS BUT CAUSES PROMINENT VIRUS-SPECIFIC T CELL RESPONSES IN THE ABSENCE OF HUMORAL IMMUNITYGujar, S. A. / Michalak, T. I. et al. | 2007
- S158
-
[412] ADENOVIRUS-MEDIATED DELIVERY OF HBV DNA IN DENDRITIC CELLS: A POTENT APPROACH TO OVERCOME IMPAIRED T-CELL REACTIVITY IN CHRONIC HEPATITIS BRiva, A. / Paulon, E. / Nathwani, A. / Taylor, J. / Naoumov, N. V. et al. | 2007
- S159
-
[415] THE ACTIVE METABOLITE OF LB80380/ANA380, A NOVEL NUCLEOTIDE ANALOG, EXHIBITS ACTIVITY IN VITRO AGAINST MULTIPLE CLINICALLY RELEVANT HEPATITIS B VIRUS MUTANTSMin, C. H. / Kim, C. R. / Steffy, K. / Averett, D. / Locarnini, S. / Shaw, T. et al. | 2007
- S163
-
[427] VALOPICITABINE (NM283) IS FULLY ACTIVE AGAINST KNOWN HCV PROTEASE RESISTANCE MUTATIONS IN VITROBichko, V. / Lallos, L. / Soubasakos, M. / LaColla, M. / Tausek, M. M. / Gillum, J. / Standring, D. N. et al. | 2007
- S165
-
[433] FK506 AMELIORATES METABOLIC DISTURBANCE AND OXIDATIVE STRESS IN HEPATITIS C VIRUS INFECTIONMoriya, K. / Miyoshi, H. / Shinzawa, S. / Tsutsumi, T. / Fujie, H. / Shintani, Y. / Yotsuyanagi, H. / Suzuki, T. / Miyamura, T. / Koike, K. et al. | 2007
- S169
-
[445] LACK OF HOST HLA IMPRINTING IN THE MAJORITY OF CONSERVED CYTOTOXIC T LYMPHOCYTE EPITOPES IN PATIENTS WITH CHRONIC HEPATITIS CAllosery, K. / Blockx, H. / Van Put, H. / Maertens, G. / Buyse, M. A. et al. | 2007
- S171
-
[450] IMMUNE ESCAPE OF HCV BY INTERNALISATION OF CHEMOKINE RECEPTOR CXCR4Herzer, K. / Schimanski, C. C. / Boger, R. / Weyer, S. / Otto, G. / Biesterfeld, S. / Mohler, M. / Galle, P. R. / Kanzler, S. et al. | 2007
- S172
-
[453] ASSOCIATION OF CCBP2, A SCAVENGER RECEPTOR FOR INFLAMMATORY CC CHEMOKINES, WITH LIVER INFLAMMATION IN MICE AND HUMANSMoreno Zaldiva, M. / Scholten, D. / Schmitz, P. / Hellerbrand, C. / Dahl, E. / Weiskirchen, R. / Trautwein, C. / Wasmuth, H. E. et al. | 2007
- S173
-
[456] NKG2A-POSITIVE CD8+ T CELLS IN CHRONIC HEPATITIS CNattermann, J. / Sherzada, R. / Bogen, D. / Iwan, A. / Nischalke, H. D. / Kramer, B. / Sauerbruch, T. / Spengler, U. et al. | 2007
- S174
-
[459] ELEVATED SERUM CONCENTRATIONS OF IP-10/CXCL10 IN HIV/HCV CO-INFECTED PATIENTSRoe, B. / Coughlan, S. / Hassan, J. / Grogan, A. / Farrell, G. / Norris, S. / Bergin, C. / Hall, W. W. et al. | 2007
- S176
-
[464] HCV CORE PROTEIN INDUCES CYTOKINE SECRETION AND PROLIFERATION IN TLR2 POSITIVE HEPATOMA CELLSNischalke, H. D. / Nattermann, J. / Sauerbruch, T. / Spengler, U. et al. | 2007
- S177
-
[467] PATHOLOGICAL ANALYSIS OF HEPATOCELLULAR MITOCHONDRIA AND OXIDATIVE STRESS IN CHRONIC HEPATITIS CTanikawa, K. / Kage, M. / Nakashima, O. / Yano, H. / Yatsuhashi, H. / Tanaka, Y. / Yagi, M. / Kojiro, M. et al. | 2007
- S178
-
[470] MAJOR SUBSETS OF INTRAHEPATIC AND PERIPHERAL BLOOD LYMPHOCYTES DURING CHRONIC HEPATITIS CTomasiewicz, K. / Modrzewska, R. et al. | 2007
- S179
-
[473] SEROLOGICAL AND MOLECULAR MARKERS OF HEPATITIS B VIRUS IN SPANISH BLOOD DONORS: EVIDENCE OF OCCULT HEPATITIS BCasamitiana, N. / Maymo, R. M. / Piron, M. / Candotti, D. / Allain, J. P. / Hernandez, J. M. / Puig, L. / Vargas, V. / Sauleda, S. et al. | 2007
- S181
-
[478] LARGE POPULATION STUDY IN LIVER STIFFNESS MEASUREMENT: PREVALENCE OF SIGNIFICANT FIBROSIS AND CORRELATION WITH LIVER BIOCHEMISTRY IN CHRONIC HEPATITIS BFung, J. / Lai, C. L. / Yuen, J. C. / Wong, O. K. / Cheng, C. T. / But, D. Y. / Yuen, M. F. et al. | 2007
- S184
-
[485] ROLE OF HBV GENOTYPES, CORE PROMOTER/PRECORE MUTATIONS AND HBVDNA LEVELS ON HEPATOCARCINOGENESISYuen, M. F. / Tanaka, Y. / Shinkai, N. / Poon, R. T. / Fung, J. / Wong, O. K. / Yuen, I. C. / Mizokami, M. / Lai, C. L. et al. | 2007
- S185
-
[487] PREDICTORS OF HBsAg REDUCTION IN HBsAg- NEGATIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON a-2a (40 kD) ALONE OR IN COMBINATION WITH LAMIVUDINEBrunette, M. / Bonino, F. / Moriconi, F. / Marcellin, P. / Lau, G. K. / Farci, P. / Yurdaydin, C. / Piratvisuth, T. / Luo, K. / Wang, Y. et al. | 2007
- S186
-
[490] GENOTYPE A2 INFLUENCE UPON THE RESPONSE TO ADEFOVIR DIPIVOXIL TREATMENTChueca, N. / Nogales, C. / Gila, A. / Suarez, E. / Puche, B. / Figueruela, B. / Pea, A. / Romero, M. / Martin, I. / Daza, R. et al. | 2007
- S187
-
[493] ADEFOVIR SALVAGE THERAPY FOR VIROLOGIC BREAKTHROUGH IN TELBIVUDINE-TREATED PATIENTS FROM THE GLOBE STUDYPane, E. / Lai, C. L. / Min, A. / Heathcote, I. / Poynard, T. / Kurdas, O. O. / Grange, J. D. / Brown, N. A. et al. | 2007
- S189
-
[498] HIGH BASELINE HBV-DNA IS LINKED TO THE EMERGENCE OF ADEFOVIR RESISTANCE IN LAMIVUDINE RESISTANT PATIENTSKaymakoglu, S. / Idilman, R. / Ahishali, E. / Onder, F. O. / Bektas, M. / Badur, S. / Bozdayi, M. / Besisik, F. / Cakaloglu, Y. / Bozkaya, H. et al. | 2007
- S190
-
[501] EFFICACY AND SAFETY OF PEG-IFN ALPHA-2b TREATMENT FOR 48 WEEKS IN ADULT THALASSAEMIC PATIENTS WITH CHRONIC HCV INFECTIONKountouras, D. / Koskinas, J. / Berdoussi, H. / Vgontza, N. / Karagiorga, M. / Lagiandreou, A. / Kaligeros, K. / Voskaridou, E. / Archimandritis, A. et al. | 2007
- S191
-
[503] OVERLAPPING OF LAMIVUDINE AND ADEFOVIR BEFORE SWITCHING TO ADEFOVIR MONOTHERAPY IN LAMIVUDINE RESISTANT CHRONIC HEPATITIS B: IS IT NECESSARY?Lee, H. I. / Lee, J. H. / Tak, W. Y. / Hwang, J. S. / Bae, S. H. / Lee, T. H. / Lee, C. K. / Baik, S. K. / Kim, M. Y. / Park, N. H. et al. | 2007
- S192
-
[506] IN VITRO PHENOTYPIC TESTING AND HBV DRUG RESISTANCE: ROLE IN DIRECTING RATIONAL ONGOING ANTIVIRAL THERAPYLocarnini, S. / Shaw, T. / Edwards, R. / Sozzi, T. et al. | 2007
- S194
-
[511] LONGITUDINAL ANALYSIS OF CYTOKINE MILIEU IN PATIENTS WITH HBeAg-POSITIVE CHB TREATED WITH ORAL ANTIVIRALS, PEGINTERFERON a-2a OR A COMBINATION OF THE TWONaoumov, N. / Hui, C. K. / Chen, J. J. / Cooksley, H. / Lau, O. K. et al. | 2007
- S196
-
[516] A RANDOMIZED TRIAL OF SWITCHING TO TELBIVUDINE VERSUS CONTINUED LAMIVUDINE IN ADULTS WITH CHRONIC HEPATITIS B: RESULTS OF THE PRIMARY ANALYSIS AT WEEK 24Safadi, R. / Xie, Q. / Chen, Y. / Yin, Y. K. / Wei, L. / Hwang, S. G. / Zuckerman, E. / Tia, J. D. / Harb, G. / Brown, N. A. et al. | 2007
- S197
-
[519] RAPID VIRAL SUPPRESSION CAN PREDICT SUSTAINED VIROLOGICAL RESPONSE TO PEGINTERFERON AND LAMIVUDINE COMBINATION TREATMENT IN CHRONIC HEPATITIS BSung, J. J. / Wong, B. W. / Chim, A. M. / Chan, H. Y. / Hui, A. Y. / Wong, G. L. / Choi, C. L. / Chan, H. L. et al. | 2007
- S199
-
[524] PREDICTORS OF RESPONSE IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B USING ADEFOVIR DIPIVOXIL THERAPYLi, J. / Zhao, H. / Si, C. W. / Zhang, Y. X. / Chen, X. Y. / Wang, L. / Tang, X. P. et al. | 2007
- S201
-
[529] LIVER STIFFNESS IN CHRONIC HEPATITIS C: WILL IT MODIFY THE ASSESSMENT OF PATIENTS?Blanc, P. L. / Gabbuti, A. / Marino, N. / Mecocci, L. / Mazzotta, F. et al. | 2007
- S202
-
[532] A NOVEL SIMPLE NONINVASIVE TEST FOR THE PREDICTION OF CIRRHOSIS IN CHRONIC HEPATITIS C: A VALIDATION AND COMPARISON OF 707 PATIENTSCross, T. J. / Rizzi, P. / Berry, P. A. / Bruce, M. / Portmann, B. / Harrison, P. M. et al. | 2007
- S203
-
[535] TNF-ALFA ACTIVATION IS ASSOCIATED WITH INSULIN RESISTANCE IN CHRONIC HEPATITIS CFartoux, L. / Maachi, M. / Wendum, D. / Bastard, J. P. / Poupon, R. / Capeau, J. / Serfaty, L. et al. | 2007
- S204
-
[538] THERAPY FOR CHRONIC HEPATITIS C IN ACTIVE INJECTORS: A NURSE LED CLINIC ALLOWS EFFECTIVE THERAPY AND LEADS TO A REDUCTION IN ILLICIT DRUG USEWilkinson, M. / Sims, E. / Tippett, A. / Hekker, M. / Dalton, J. / Turton, J. / Jolly, F. / Crawford, V. / Marley, R. / Foster, G. R. et al. | 2007
- S205
-
[541] CONFIRMATION OF THE ACCURACY OF FIB-4, A SIMPLE MARKER OF FIBROSIS IN HCV PATIENTS WITH AND WITHOUT HIV CO-INFECTIONGaleras, J. A. / Timeno, M. / Tural, C. / Cirera, I. / Panades, A. / Seoane, A. / Barranco, C. / Gimenez, M. D. / Marquez, C. / Ojanguren, I. et al. | 2007
- S207
-
[546] THE VALUE OF PEGINTERFERON o-2a THERAPY FOR CHRONIC C HEPATITIS IN HEMODIALYSED PATIENTSlonita-Radu, F. / Nuta, P. / Fanea, F. / Petrescu, L. / Klein, C. / Popescu, D. / Nicolescu, I. / Nicolaie, T. / Rotaru, A. / Ionescu, R. et al. | 2007
- S209
-
[551] HYPERHOMOCYSTEINEMIA IN CHRONIC HEPATITIS C: ROLE IN STEATOSIS, FIBROGENESIS AND RESPONSE TO ANTIVIRAL TREATMENTRoblin, X. / Ducros, V. / Hilleret, M. N. / Sturm, N. / Plages, A. / Zarski, J. P. / Leroy, V. et al. | 2007
- S210
-
[554] VARIATION OF HEPATITIS C (HC) DETECTION RATE IN A FRENCH POPULATION ACCORDING TO SOCIO-ECONOMIC CONTEXT AND DISTANCE TO MEDICAL CAREMonnet, E. / Ramee, C. / Minello, A. / Collin, E. / Jooste, V. / Evrard, P. / Carel, D. / Miguel, J. P. / Hillon, P. / Di Martino, V. et al. | 2007
- S211
-
[557] HEPATITIS C VIRUS CARRIERS WITH NORMAL ALANINE AMINOTRANSFERASES: ANALYSIS OF FACTORS INVOLVED IN FIBROSIS PROGRESSIONRapetti, R. / Fabris, C. / Aguggia, L. / Minisini, R. / Franchini, L. / Mella, R. / Toniutto, P. / Smirne, C. / Colletta, C. / Vandelli, C. et al. | 2007
- S215
-
[567] HCV HEPATITIS AND INTERFERON-RELATED DEPRESSION: AN ANALYSIS OF THE RETROSPECTIVE PHASE OF THE PROBE STUDYAmodio, P. / Montebianco Abenavoli, S. / Cosco, L. / Ferrari, C. / Patriarchi, R. / Coppola, C. / Piccinino, F. / Sani, S. / Passariello, N. / Babudieri, S. et al. | 2007
- S217
-
[572] RANDOMIZED, OPEN LABEL TRIAL COMPARING EFFICACY AND SAFETY OF PEGYLATED INTERFERON ALFA 2b VS ALFA 2b TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C INFECTED WITH NON 2/3 GENOTYPES - FINAL ANALYSISBerak, H. / Kolakowska-Rzadzka, A. / Wasilewski, M. / Kowalska, J. / Stanczak, J. J. / Bardadin, K. / Horban, A. et al. | 2007
- S218
-
[575] PREDICTION OF TREATMENT RESPONSE TO 72 WEEKS OF PEGYLATED INTERFERON ALFA-2a PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C AFTER LIVER TRANSPLANTATIONBergk, A. / Neumann, U. P. / van Boemmel, F. / Wiedenmann, B. / Berg, T. / Neuhaus, R. et al. | 2007
- S219
-
[578] DOES ADJUVANT THERAPY WITH ERYTHROPOIETIN AND GCSF IMPROVE SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS RECEIVING COMBINATION THERAPY WITH PEGYLATED INTERFERON AND RIBAVIRIN FOR CHRONIC HEPATITIS C?Cash, W. J. / Patterson, K. / Callender, M. E. / McDougall, N. I. et al. | 2007
- S220
-
[581] TRANSFORMING GROWTH FACTOR-p1 GENE POLYMORPHISMS IN CHRONIC HEPATITIS C. INFLUENCES FIBROSIS STAGING AND THE TYPE OF ANTIVIRAL RESPONSE?Conde, M. / Serejo, F. S. / Langa, V. / Bicho, M. P. / Moura, M. C. et al. | 2007
- S221
-
[584] A POTENTIAL PROGNOSTIC TEST FOR PREDICTION OF HCV RESPONSE TO IFN THERAPYEl Awady, M. K. / Hassan, R. M. / Omran, M. H. / Hefnawy, M. M. / Zayady, A. E. et al. | 2007
- S222
-
[587] ANTIVIRAL TREATMENT PROFOUNDLY AFFECTS IRON STATUS IN HCV PATIENTS: IMPLICATIONS FOR MANAGEMENT AND TREATMENT OUTCOMEFerrara, F. / Guido, M. / Ventura, P. / Geetti, A. / Abbati, G. / Corradini, E. / Ferrari, C. / Fattovich, G. / Pietrangelo, A. et al. | 2007
- S224
-
[592] NEOPTERIN AND ALT AS MARKERS OF INFLAMMATION IN CHRONIC HEPATITIS C PATIENTS DURING ADMINISTRATION OF THE HCV NS3-4A PROTEASE INHIBITOR TELAPREVIR (VX-950) IN COMBINATION WITH PEGINTERFERON ALFA 2aGelderblom, H. C. / Zeuzem, S. / Weegink, C. T. / Forestier, N. / McNair, L. / Purdy, S. / Tansen, P. L. / Reesink, H. W. et al. | 2007
- S225
-
[595] CLINICAL COURSE OF HEPATITIS C VIRUS INFECTION IN RENAL TRANSPLANT RECIPIENTSSavas, N. / Yilmaz, U. / Colak, T. / Karakayali, H. / Haberal, M. et al. | 2007
- S226
-
[598] INTERFERON INDUCED GENE INDUCTION AND THE ANTI-VIRAL EFFECTS OF IFN ALPHA IN LIVER BIOPSIES WITH HEPATITIS C: VIRAL AND HOST RESPONSES DETERMINE TREATMENT EFFICACYHibbert, L. / Foster, G. R. et al. | 2007
- S227
-
[601] DOUBLE FILTRATION PLASMAPHERESIS AND (PEG) INTERFERON/RIBAVIRIN COMBINATION THERAPY IN CHRONIC HEPATITIS C PATIENTSIde, T. / Kaneko, S. / Kakumu, S. / Mochida, S. / Sata, M. / Fujiwara, K. et al. | 2007
- S228
-
[604] COMPARISON OF A SHORTENED RIBAVIRIN TREATMENT VS A 24 WEEK STANDARD COMBINATION THERAPY IN HCV INFECTED PATIENTS WITH GENOTYPE 2/3Kallinowski, B. / Stein, K. / Boecher, W. / Goeser, T. / Spengler, U. / Link, R. / Klinker, H. / Bruckner, T. / Haiss, P. / Buggisch, P. et al. | 2007
- S230
-
[609] TELAPREVIR (VX 950)-RESISTANT VARIANTS EXHIBIT REDUCED REPLICATION CAPACITY COMPARED TO WILD-TYPE HCV IN VIVO AND IN VITROChu, H. M. / Zhou, Y. / Bartels, D. T. / Khunvichai, A. / Rao, B. G. / Kwong, A. D. / Lin, C. et al. | 2007
- S231
-
[613] VIROLOGICAL RESPONSE AT 4 AND 12 WEEKS PREDICT HIGH RATES OF SUSTAINED VIROLOGICAL RESPONSE IN GENOTYPE 1 PATIENTS TREATED WITH PEGINTERFERON a-2a (40 kD) PLUS RIBAVIRINMarcellin, P. / Hadziyannis, S. J. / Berg, T. / Sanchez-Tapias, J. M. / Bronowicki, J. P. / Sakai, T. / Lin, A. / Tietz, A. / Ferenci, P. et al. | 2007
- S232
-
[615] MANAGEMENT OF CHRONIC HEPATITIS C IN A DIVERSE POPULATION WITH PEGINTERFERON tt-2a AND RIBAVIRIN: FINAL RESULTS OF THE CANADIAN PEGASYS EXPANDED ACCESS PROGRAM (EAP)Deschenes, M. / Yoshida, E. / Peltekian, K. / Cooper, C. / Bain, V. / Krajden, M. / Sherman, M. / Lee, S. S. / Balshaw, R. / Marotta, P. et al. | 2007
- S234
-
[620] CHARACTERIZATION OF PHARMACOKINETIC/PHARMACODYNAMIC PARAMETERS FOR THE NOVEL HCV POLYMERASE INHIBITOR A-848837Molla, A. / Wagner, R. / Lu, L. / He, D. / Chen, C. M. / Koev, G. / Masse, S. / Cai, Y. / Klein, C. / Beno, D. et al. | 2007
- S235
-
[623] THE GNB3 C825T POLYMORPHISM AFFECTS RESPONSE TO HCV THERAPY WITH PEGYLATED INTERFERON IN HCV/HIV CO-INFECTED BUT NOT IN HCV MONO-INFECTED PATIENTSNattermann, J. / Bueren, K. / Nischalke, H. / Ahlenstiel, G. / Berg, T. / Biermer, M. / Sauerbruch, T. / Vogel, M. / Rockstroh, J. / Spengler, U. et al. | 2007
- S236
-
[626] PRE-DOSING TARIBAVIRIN PRIOR TO COMBINATION THERAPY WITH PEGYLATED INTERFERON ALFA-2b VERSUS STANDARD COMBINATION DOSING: 24-WEEK INTERIM RESULTS EXAMINING SAFETY AND VIRAL KINETICSPalmer, M. / Rubin, R. / Rustgi, V. / Li, D. / Murphy, B. et al. | 2007
- S237
-
[628] USE OF LOW-DOSE PEGINTERFERON a-2a (40 kD) (PEGASYS) TO TREAT HEPATITIS C-INFECTED END-STAGE RENAL DISEASE PATIENTS UNDERGOING HAEMODIALYSIS: INTERIM RESULTS FROM A RANDOMISED STUDYPeck-Radosavljevic, M. / Boletis, J. / Besisik, F. / Lucia Ferra, M. / Alric, L. / Samuel, D. / Messinger, D. / Junker, H. / Cheinquer, H. et al. | 2007
- S238
-
[631] INFLUENCE OF THE PERSISTENCE OF NS3 HCV ANTIGEN IN LIVER TISSUE AFTER ANTIVIRAL TREATMENT ON INFLAMMATORY ACTIVITY AND FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS CPisula, A. / Janczewska-Kazek, E. / Ziolkowski, A. / Zajecki, W. / Marek, B. / Boron-Kaczmarska, A. et al. | 2007
- S240
-
[637] LIPID STEATOSIS, METABOLIC VARIABLES AND BODY COMPOSITION IN THE SETTING OF HIV/HCV COINFECTION; FINDINGS FROM A LARGE RANDOMIZED TRIALRodriguez-Torres, M. / Govindarajan, S. / Sola, R. / Clumeck, N. / Lissen, E. / Pessoa, M. / Buggisch, P. / Main, I. / DePamphilis, J. / Dieterich, D. T. et al. | 2007
- S241
-
[640] BASELINE FACTORS ASSOCIATED WITH ANEMIA DURING PEGYLATED INTERFERON PLUS RIBAVIRIN COMBINATION THERAPY FOR CHRONIC HEPATITIS CSampaio, J. P. / El Batah, P. N. / Schiavon, L. L. / Carvalho Filho, R. J. / Narciso, J. L. / Ferraz, M. L. / Silva, A. E. et al. | 2007
- S242
-
[642] THE EXPRESSION OF LIVER PROGENITOR CELLS -PREDICTIVE FACTOR OF ANTIVIRAL THERAPY RESPONSE IN PATIENTS WITH GENOTYPE 1 VIRAL C CHRONIC HEPATITISRogoveanu, I. / Sandulescu, D. L. / Ciurea, T. / Gheonea, D. I. / Comanescu, V. / Badea, P. et al. | 2007
- S244
-
[647] SEQUENCE VARIATION OF NS3/4A IN HCV REPLICONS EXPOSED TO ITMN-191 CONCENTRATIONS ENCOMPASSING THOSE LIKELY TO BE ACHIEVED FOLLOWING CLINICAL DOSINGSeiwert, S. D. / Hon, J. / Lim, S. R. / Wang, T. / Tan, H. / Blatt, L. M. et al. | 2007
- S245
-
[649] CPG 10101 (ACTILON) IN COMBINATION WITH PEGYLATED INTERFERON AND/OR RIBAVIRIN IN CHRONIC HCV GENOTYPE 1 INFECTED PATIENTS WITH PRIOR RELAPSED RESPONSE: WEEK 48 DATAShiftman, M. L. / Ghalib, R. / Lawitz, E. / Freilich, B. / Gordon, S. C. / Kwo, P. Y. / Riley, T. R. / Schiff, E. / Flamm, S. / Jacobson, I. M. et al. | 2007
- S247
-
[654] PREDICTION OF VIROLOGIC RESPONSE IN HCV GENOTYPE 1A-INFECTED PATIENTS ACCORDING TO AMINO ACID PATTERN IN NS5A USING STATISTICAL LEARNING ALGORITHMS FOR CLASSIFICATIONvon Wagner, M. / Welsch, C. / Herrmann, E. / Sarrazin, C. / Kau, A. / Welker, M. / Fernandez, B. / Merkwirth, C. / Pawlotsky, T. M. / Neumann, A. et al. | 2007
- S250
-
[661] ROLE OF THE CD26/ADA/ADENOSINE SYSTEM IN VIRAL AND AUTOIMMUNE CHRONIC LIVER DISEASESBroelsch, G. F. / Teffe, F. / Schlaphoff, V. / Martinez, B. C. / Ciner, A. / Cornberg, M. / Manns, M. P. / Wedemeyer, H. et al. | 2007
- S251
-
[664] DETECTION OF MND AND RL/M ANTI-NUCLEAR ANTIBODIES PATTERNS: A RELIABLE DIAGNOSTIC TOOL IN ANTI-MITOCHONDRIAL ANTIBODIES NEGATIVE PRIMARY BILIARY CIRRHOSISdGranito, A. / Pappas, G. / Muratori, P. / Muratori, L. / Ferri, S. / Quarneti, C. / De Molo, C. / Cipriano, V. / Cassani, F. / Worthington, J. et al. | 2007
- S252
-
[667] INFLUENCE OF URSODEOXYCHOLIC ACID ON THE MORTALITY AND MORBIDITY ASSOCIATED WITH PRIMARY BILIARY CIRRHOSIS: A POPULATION-BASED COHORT STUDYJackson, H. R. / Solaymani-Dodaran, M. / Card, T. R. / Aithal, G. P. / Logan, R. et al. | 2007
- S253
-
[670] A NEW SUBSTRATE FACILITATES THE DETECTION OF AUTOIMMUNE HEPATITIS SPECIFIC ANTI-SMOOTH MUSCLE ANTIBODIESBogdanos, D. P. / Komorowski, L. / Liaskos, C. / Davies, E. T. / Mieli-Vergani, G. / Dalekos, G. N. / Vergani, D. et al. | 2007
- S256
-
[679] EFFECTIVENESS OF HAEMOCHROMATOSIS MANAGEMENT AT A GENERAL LIVER CLINICMcCloskey, M. / Cash, W. J. / McDougall, N. I. / Callender, M. E. et al. | 2007
- S257
-
[682] INTRAUTERINE-TRANSPLACENTAL TRANSMISSION OF HEPATITIS B VIRUS (HBV) INFECTION FROM VIREMIC (PRECORE MUTANT, G1896A) CHRONIC HBV INFECTED MOTHERS TO THEIR INFANTSElefsiniotis, I. S. / Papadakis, M. / Vlachos, G. / Daskalakis, G. / Barbatis, C. / Antsaklis, A. et al. | 2007
- S259
-
[687] FAMILIAL NONCIRRHOTIC PORTAL HYPERTENSION DUE TO CONGENITAL PORTAL VENOUS ANOMALY: A NEW SYNDROMESatoskar, R. S. / Hart, I. / Jensen, D. M. et al. | 2007
- S260
-
[690] EXPRESSION OF HEPATIC LEPTIN RECEPTORS IN PATIENTS WITH NAFLDGagalis, A. / Akriviadis, E. / Kotoula, V. / Hytiroglou, P. et al. | 2007
- S261
-
[693] MICROARRAY ANALYSIS DEMONSTRATES INSULIN RESISTANCE IS CENTRAL TO NASH PATHOGENESIS IN THE IGT/6 MODEL AND SUGGESTS A ROLE FOR CEACAM-1 IN DISEASE PATHOGENESISAnstee, Q. M. / Goldsworthy, M. / Goldin, R. / Thomas, H. C. / Cox, R. / Thursz, M. et al. | 2007
- S263
-
[698] ALLELE AND GENOTYPE FREQUENCIES OF POLYMORPHIC CYP2E1, ADH2 AND ALDH2 IN A HUICHOL POPULATIONBastidas-Ramirez, B. E. / Zepeda-Carrillo, E. / Gordillo-Bastidas, E. / Gordillo-Bastidas, D. / Gonzalez-Hita, M. / Garcia-Banuelos, J. I. / Panduro, A. et al. | 2007
- S264
-
[701] PENTOXIFYLLINE FOR TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD): A RANDOMIZED, PLACEBO-CONTROLLED STUDYBuranawuti, W. / Thong-u-thaisri, P. / Pramoolsinsap, C. / Wisedopas, N. / Atamasirikul, K. / Udomsubpayakul, U. et al. | 2007
- S265
-
[704] MITOCHONDRIAL DNA HAPLOGROUPS ASSOCIATED WITH HISTOLOGICAL SEVERITY IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)De Alwis, N. M. / Mowbray, C. / Pyle, A. / Henderson, E. / Leathart, J. / Aithal, G. P. / Chinnery, P. F. / Day, C. P. et al. | 2007
- S266
-
[706] NON ALCOHOLIC FATTY LIVER DISEASE ASSOCIATED WITH NORMAL ALT VALUES: A CLINICOPATHOLOGIC STUDYDixit, V. K. / Somani, A. / Jain, A. K. / Vashistha, P. / Kate, M. P. / Bhattacharya, A. / Hasan, H. et al. | 2007
- S267
-
[709] BASELINE ALT AND FERRITIN PREDICT HISTOLOGICAL FINDINGS IN NAFLDFracanzani, A. L. / Valenti, L. / Fatta, E. / Bertelli, C. / Pulixi, E. / Fargion, S. et al. | 2007
- S268
-
[712] IS LIVER STIFFNESS MEASUREMENT DIFFERENT IN PATIENTS WITH NASH OR WITH VIRAL HEPATITIS?Gaia, S. / Carenzi, S. / Brunello, F. / Barilli, A. / Lagget, M. / Smedile, A. / Rizzetto, M. et al. | 2007
- S269
-
[715] EVALUATION OF LIVER DAMAGE IN HIV-1 -POSITIVE PATIENTS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) WITH CHRONIC TRANSAMINASES ELEVATION OF UNKNOWN ORIGIN (THE HEALTH STUDY)Ingiliz, P. / Valantin, M. A. / Duvivier, C. / Simon, A. / Dominguez, S. / Tubiana, R. / Falconer, K. / Charlotte, F. / Katlama, C. / Benhamou, Y. et al. | 2007
- S271
-
[720] "ALCOHOLIC HEPATITIS" AFTER GASTROINTESTINAL BLEEDING HAS A GOOD PROGNOSISLafferty, H. D. / Johnson, V. / Keith, R. / Morris, A. J. / Stanley, A. J. / Forrest, E. H. et al. | 2007
- S272
-
[723] LIVER MITOCHONDRIAL FUNCTION AND BIOGENESIS IN PATIENTS WITH NAFLD: HEPATIC EXPRESSION OF PGC1-ALPHA, COX2 AND COX4Lemoine, M. / Kim, M. / Ratziu, V. / Barbu, V. / Bastard, J. P. / Wendum, D. / Paye, F. / Poupon, R. / Housset, C. / Capeau, J. et al. | 2007
- S275
-
[731] IMPACT OF MODERATE ALCOHOL CONSUMPTION ON HEPATIC FIBROSIS PROGRESSION IN HCV-INFECTED PATIENTSMarine Barjoan, E. / Gelsi, E. / Delasalle, P. / Ibragimova, N. / Sattonnet, C. / Saint-Paul, M. C. / Gueyffier, C. / Diebolt, E. / Hayek, R. / Fuzibet, J. G. et al. | 2007
- S277
-
[737] THE EFFECT OF INSULIN-SENSITIZING AGENTS IN THE TREATMENT OF INDIVIDUALS WITH NON-ALCOHOLIC STEATOHEPATITISMizrak, D. / Idilman, R. / Bektas, M. / Erden, E. / Soykan, I. / Corapcioglu, D. / Doganay, B. / Emral, R. / Uysal, A. R. / Ozden, A. et al. | 2007
- S278
-
[740] ASSESSMENT OF LIVER FIBROSIS USING LIVER STIFFNESS MEASUREMENT (LSM) IN PATIENTS WITH ALCOHOLIC LIVER DISEASENahon, P. / Ziol, M. / de Ledinghen, V. / Douvin, C. / Marcellin, P. / Ganne-Carrie, N. / Trinchet, J. C. / Beaugrand, M. et al. | 2007
- S279
-
[743] IMMUNE RESPONSES AND FIBROSIS IN ALCOHOLIC HEPATITISNeuman, M. G. / Katz, G. G. / Malkiewitz, I. / Benhamou, J. P. / Marcelin, P. / Valla, D. C. / Bourliere, M. / Schmilovitz-Weiss, H. / Ben-Ari, Z. / Tur-Kaspa, R. et al. | 2007
- S280
-
[746] N-ACETYL-CYSTEIN BLOCKS PROGRESSION OF NASH BY REDUCING REACTIVE OXYGEN SPECIES. AN EXAMINATION USING HEPATOCYTE-SPECIFIC Pten DEFICIENT MICEOhshima, S. / Dohmen, T. / Goto, T. / Anezaki, Y. / Ishii, H. / Kataoka, E. / Sato, W. / Yoneyama, K. / Shibuya, T. / Yamada, I. et al. | 2007
- S282
-
[752] DRUG-INDUCED HEPATITIS IN PATIENTS HOSPITALIZED FOR ABNORMAL LIVER TESTSPrisco, C. / Vinci, M. / Belli, L. S. / Pinzello, G. et al. | 2007
- S284
-
[758] AUDIT AND PREDICTIVE FACTORS FOR ALCOHOL CONSUMPTION POST LIVER TRANSPLANTATION -MUST TRY HARDER?Shusang, V. / Shepherd, L. / Cholongitas, E. / Senzolo, M. / Manousou, P. / Marelli, L. / Patch, D. / Burroughs, A. K. et al. | 2007
- S285
-
[761] FAMILIAL CLUSTERING OF NON ALCOHOLIC FATTY LIVER DISEASE: DOES INSULIN RESISTANCE HOLD THE KEY?Somani, A. / Dixit, V. K. / Jain, A. K. / Bhattacharya, A. / Hasan, H. et al. | 2007
- S287
-
[766] NON INVASIVE TESTS OF LIVER FIBROSIS IN NAFLDTropet, A. L. / Laine, F. / de Ledinghen, V. / Deugnier, Y. / Oberti, F. / Dib, N. / Rousselet, M. C. / Cadranel, J. F. / Ratziu, V. / Causse, X. et al. | 2007
- S288
-
[769] IRON DEPLETION BY PHLEBOTOMY IMPROVES INSULIN RESISTANCE IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE AND HYPERFERRITINEMIA; EVIDENCE FROM A CASE CONTROL STUDYValenti, L. / Fracanzani, A. L. / Dongiovanni, P. / Bugianesi, E. / Vanni, E. / Marches, G. / Fargion, S. et al. | 2007
- S294
-
[783] SHORT-TERM ANTIVIRAL ACTIVITY AND SAFETY OF ACH-806 (GS-9132), AN NS4A ANTAGONIST, IN HCV GENOTYPE 1 INFECTED INDIVIDUALSPottage, J. C. / Lawitz, E. / Mazur, D. / Wyles, D. / Vargas, H. / Ghalib, R. / Gugliotti, R. / Donohue, M. / Robison, H. et al. | 2007
- S295
-
[785] RECOMBINANT FACTOR VIIA (RFVIIA) FOR ACTIVE VARICEAL BLEEDING IN PATIENTS WITH ADVANCED CIRRHOSIS: A MULTI-CENTRE RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIALBosch, J. / Thabut, D. / Albillos, A. / Carbonell, N. / Spicak, J. / Massard, J. / DAmico, G. / Lebrec, D. / de Franchis, R. / Fabricius, S. et al. | 2007
- S297
-
[790] IN VITRO RESISTANCE SELECTION TO THE HCV NUCLEOSIDE POLYMERASE INHIBITOR R1479 AND TO THE PROTEASE INHIBITOR VX-950McCown, M. / Rajyaguru, S. / Symons, J. / Cammack, N. / Naiera, I. et al. | 2007
- S298
-
[793] COMBINATION OF TWO HEPATITIS C VIRUS INHIBITORS, SCH 503034 AND NM107, PROVIDES ENHANCED ANTI-REPLICON ACTIVITY AND SUPPRESSES EMERGENCE OF RESISTANT REPLICONSRalston, R. / Bichko, V. / Chase, R. / LaColla, M. / Lallos, L. / Skelton, A. / Soubasakos, M. / Tausek, M. / Tong, X. / Standring, D. et al. | 2007
- S301
-
Author Index| 2007
- XIX
-
Subject Index| 2007
-
Become Part of Our Vision!| 2007
-
42nd Annual Meeting of EASL| 2007
-
[5] ABSENCE OF FXR PROTECTS MICE FROM BILE-INFARCTS IN BILIARY OBSTRUCTION BY REDUCTION OF BILE ACID-INDEPENDENT BILE FLOW: IMPLICATIONS FOR TARGETING FXR IN TREATMENT OF CHOLESTASIS?Wagner, M. / Moustafa, T. / Fickert, P. / Zollner, G. / Gumhold, J. / Silbert, D. / Fuchsbichler, A. / Zatloukal, K. / Denk, H. / Trauner, M. et al. | 2007
-
[7] IN PTS WHO CLEAR HCVRNA AT WEEK 12, SVR IS HIGHER AFTER 72 THAN AFTER 48 WEEKS TX: RESULTS OF A RANDOMIZED CONTROLLED TRIAL (RCT)Mangia, A. / Minerva, N. / Bacca, D. / Carretta, V. / Vuturo, N. / Ricci, G. L. / Romano, M. / Cela, M. / Scotto, G. / Cristoforo, G. et al. | 2007
-
[26] ANTIGEN PRESENTATION BY BONE-MARROW DERIVED ANTIGEN PRESENTING CELLS IS REQUIRED FOR EFFECTIVE T-CELL PRIMING IN AN ANIMAL MODEL OF AUTOIMMUNE LIVER DISEASEDerkow, K. / Kruse, N. / Klugewitz, K. / Wiedenmann, B. / Schott, E. et al. | 2007
-
[31] THE IMMUNO-PROTECTIVE EFFECT OF THE LIVER AS PART OF A COMPOSITE VISCERAL GRAFT: THE IMPACT ON SURVIVAL AND LONG-TERM OUTCOMEAbu-Elmagd, K. M. / Mazariegos, G. / Bond, G. T. / Murase, N. / Wu, T. / Costa, G. / Soltys, K. / Sindhi, R. / Demetris, A. T. / Marcos, A. et al. | 2007
-
[37] OUTCOME OF PATIENTS TRANSPLANTED FOR PRIMARY SCLEROSING CHOLANGITIS - ANALYSIS OF THE EUROPEAN LIVER TRANSPLANT REGISTRYSchramm, C. / Bubenheim, M. / OGrady, J. G. / Buckels, J. / Pollard, S. / Neuhaus, P. / Jamieson, N. / Klempnauer, J. / Rogiers, X. / Karam, V. et al. | 2007
-
[40] DIFFERENTIAL REGULATION OF CYCLIN D1 AND APOPTOSIS BY BILE ACIDS IN PRIMARY RAT HEPATOCYTESCastro, R. E. / Amaral, J. D. / Sola, S. / Kren, B. T. / Steer, C. J. / Rodrigues, C. M. et al. | 2007
-
[94] PERSISTENT IMPAIRMENT OF HCV-SPECIFIC CDS CELL RESPONSE IN HCV-RNA NEGATIVE PATIENTS AFTER SUCCESSFUL PEG-INTERFERON/RIBAVIRIN TREATMENTMissale, G. / Pilli, M. / Penna, A. / Zerbini, A. / Sacchelli, L. / Mori, C. / Mezzadri, S. / Ferrari, C. et al. | 2007
-
[104] FUNCTIONAL AND GENETIC INTERACTION OF THE CHEMOKINES CCL (RANTES) AND CXCL (PF) IN CHRONIC LIVER DISEASES IN MICE AND HUMANSScholten, D. / Dahl, E. / Beraza, N. / Lammert, F. / Hellerbrand, C. / Weiskirchen, R. / Weber, C. / Trautwein, C. / Wasmuth, H. E. et al. | 2007
-
[120] HEPATITIS C E2 KINASE CONTROLS ENDOCYTOSIS AND PROLIFERATIONBuck, M. M. et al. | 2007
-
[148] HRAR SCALE, PSYCHIATRIC COMORBIDITIES AND THE SIX MONTH ABSTINENCE RULE AS PREDICTORS OF HARMFUL ALCOHOL RELAPSE AFTER LIVER TRANSPLANTATIONDe Gottard, A. / Spahr, L. / Gelez, P. / Morard, I. / Mentha, G. / Majno, P. / Morel, P. H. / Hadengue, A. / Paliard, P. / Boillot, O. et al. | 2007
-
[163] CORRELATION BETWEEN HEPATOCYTE AND HEPATIC PROGENITOR CELL REGENERATION AND MODEL FOR END STAGE LIVER DISEASE (MELD) SCORE IN ACUTE SEVERE LIVER IMPAIRMENTKatoonizadeh, A. / Nevens, F. / Verslype, C. / Pirenne, J. / Roskams, T. et al. | 2007
-
[172] DETECTION OF HCV ANTIGENS IN EARLY POST-LIVER TRANSPLANT GRAFT BIOPSIES PREDICTS RECURRENT HEPATITIS C AFTER 1 YEAR IN PATIENTS TRANSPLANTED FOR HCV RELATED LIVER DISEASEGrassi, A. / Ouarneti, C. / Susca, M. / Ravaioli, M. / Cipriano, V. / DErrico, A. / Morelli, C. / Piscaglia, F. / Tame, M. / Andreone, P. et al. | 2007
-
[177] THE MELD-SERUM SODIUM RELATION IN PATIENTS WITH END STAGE LIVER DISEASESelcuk, H. / Uruc, I. / Temel, M. A. / Ocal, S. / Korkmaz, M. / Unal, H. / Savas, N. / Gur, G. / Yilmaz, U. / Haberal, M. et al. | 2007
-
[189] RESOLUTION OF THIOACETAMIDE-INDUCED LIVER FIBROSIS IN RATS TREATED WITH PENTOXYPHYLLINEBuko, V. / Popov, Y. / Lis, R. / Zaks, J. / Schuppan, D. / Lukivskaya, O. et al. | 2007
-
[231] CEREBRAL MAGNETIC RESONANCE IMAGING REVEALS FINDINGS COMPATIBLE WITH GRAY AND WHITE MATTER LOSS IN PATIENTS WITH CIRRHOSISBaccaro, M. E. / Guevara, M. / Gomez-Anson, B. / Testa, C. / Frisoni, G. B. / Torre, A. / Monte-Rubio, G. C. / Pepin, M. N. / Martin-Llahi, M. / Terra, C. et al. | 2007
-
[234] CARDIAC EFFECTS OF TERLIPRESSIN IN CIRRHOSI S. UNMASKING A CIRRHOTIC CARDIOMYOPATHY?Krag, A. / Bendtsen, F. / Henriksen, J. H. / Moller, S. et al. | 2007
-
[235] LIMITED ROLE FOR ROUTINE ASCITIC CULTURE AS A DIAGNOSTIC TOOL FOR SPONTANEOUS BACTERIAL PERITONITIS IN THE ERA OF PROPHYLACTIC ANTIBIOTICSKuiper, J. J. / van Buuren, H. R. / de Man, R. A. et al. | 2007
-
[295] MOLECULAR EVENTS ASSOCIATED WITH ALPHA-LIPOIC ACID-INDUCED APOPTOSIS OF HEPATOMA CELLSSimbula, G. / Columbano, A. / Ledda-Columbano, G. M. / Sanna, L. / Deidda, M. / Diana, A. / Pibiri, M. et al. | 2007
-
[300] HEPATIC EXPRESSION OF NUCLEAR RECEPTORS AND BILIARY TRANSPORTERS IN HUMAN CHOLESTEROL GALLSTONE DISEASEBertolotti, M. / Gabbi, C. / Anzivino, C. / Tagliafico, E. / Carulli, L. / Rossi, A. / Loria, P. / Carulli, N. et al. | 2007
-
[314] CHOLANGIOCARCINOMA CELLS ARE SUSCEPTIBLE TO THE MODULATION OF CELL GROWTH BY ENDOGENOUS OPIOID PEPTIDES BUT RESPOND WITH INCREASED PROLIFERATIONMarzioni, M. / Saccomanno, S. / Fava, G. / Candelaresi, C. / Rychlicki, C. / Alpini, G. / Benedetti, A. et al. | 2007
-
[322] DISSECTING EPIGENETIC ALTERATIONS BETWEEN HEPATITIS B VIRUS AND HEPATITIS C VIRUS-INFECTED HEPATOCELLULAR CARCINOMA USING CpG ISLAND MICROARRAYChen, C. M. / Chen, W. E. / Chen, C. Y. / Wu, J. C. / Chen, H. L. et al. | 2007
-
[330] AMPHIREGULIN, A GROWTH FACTOR OF THE EGF FAMILY, PARTICIPATES IN THE DEVELOPMENT OF LIVER FIBROSISNicou, A. / Castillo, J. / Perugorria, M. J. / Latasa, M. U. / Prieto, J. / Berasain, C. / Avila, M. A. et al. | 2007
-
[350] EFFECT OF STAT3 INHIBITOR PICEATANNOL ON HUMAN DENDRITIC CELL HOMEOSTASIS AND GROWTH OF HEPATOCELLULAR CARCINOMA IN VITROCicinnati, V. R. / Kang, J. / Klein, C. G. / Broelsch, C. E. / Gerken, G. / Beckebaum, S. et al. | 2007
-
[359] C-AMP ACTIVATION PREVENTS INHIBITORY TRANSCRIPTION FACTORS BINDING TO THE HGF PROMOTER (-253 TO -277) RELIEVING THE NUCLEAR FACTOR-INDUCED REPRESSION OF HGF PROMOTER ACTIVITYHarrison, P. M. / Farzaneh, F. et al. | 2007
-
[367] MEMORY READ OUT OF HYPOXIA-INDUCIBLE FACTOR (HIF) 1 ALPHA AS NOVEL TOOL TO DETERMINE TISSUE OXYGEN: EVIDENCE FOR HYPOXIC HEPATOCELLULAR OXYGEN LEVELS IN VIVOMillonig, G. / Hegeduesch, S. / Schuppan, D. / Mueller, S. et al. | 2007
-
[368] USE OF G-CSF DURING ACUTE ON CHRONIC LIVER FAILURE: CLINICAL AND BIOCHEMICAL SAFETY PROFILENovi, M. / Zocco, M. A. / Di Campli, C. / Di Gioacchino, G. / Rutella, S. / Rinninella, E. / Ainora, M. E. / Leone, G. / Gasbarrini, G. / Rapaccini, G. L. et al. | 2007
-
[374] INHIBITION OF HEPATIC TUMOUR ANGIOGENESIS WITH Met INHIBITORSPiguet, A. C. / Aebersold, D. M. / Hofstetter, W. / Dufour, J. F. / Zimmer, Y. et al. | 2007
-
[392] POSTTRANSCRIPTIONAL VEGF INHIBITION REDUCES TUMOR GROWTH IN AN EXPERIMENTAL MURINE HCC MODELRaskopf, E. / Vogt, A. / Kornek, M. / Sauerbruch, T. / Schmitz, V. et al. | 2007
-
[424] TLR9 EXPRESSION AND FUNCTIONAL IMPAIRMENT OF PLASMACYTOID DENDRITIC CELLS IN PATIENTS WITH CHRONIC HEPATITIS B INFECTIONJia, N. N. / Xie, Q. / An, B. Y. / Shen, H. C. / Gui, H. L. / Lin, L. Y. / Wang, H. / Zhou, X. Q. / Yu, H. / Guo, Q. et al. | 2007
-
[425] DIFFERENTIALLY METHYLATED GENES MAY CONTRIBUTE TO PHENOTYPE DIFFERENCES FOR HBV INFECTION IN MONOZYGOTIC TWIN PAIRSXu, B. Y. / Wang, Y. M. / Deng, G. H. et al. | 2007
-
[426] THE ASSOCIATION BETWEEN GENOTYPE AND HEPATITIS B VIRAL LOAD MAY DEPEND ON HBeAg SEROSTATUS: THE R.E.V.E.A.L.-HBV STUDYYang, H. I. / Su, J. / Chen, P. J. / Iloeje, U. H. / Yeh, S. H. / Jen, C. L. / You, S. L. / Chen, D. S. / Chen, C. T. et al. | 2007
-
[466] TLR-MEDIATED SUBVERSION OF INNATE IMMUNITY IN CHRONIC HCV INFECTION: AUGMENTATION OF MONOCYTE TNFa LEADS TO DECREASED IFN-o PRODUCTION BY PLASMACYTOID DENDRITIC CELLSSzabo, G. / Dolganiuc, A. / Chang, S. / Kodys, K. et al. | 2007
-
[468] PHENOTYPIC FEATURES OF CIRCULATING LYMPHOCYTES AND ITS ASSOCIATION WITH CRHONIC HEPATITIS C AND END-STAGE RENAL DISEASEBarbosa, K. V. / Bassetti-Soares, E. / Teixeira, R. / Martins Filho, O. A. et al. | 2007
-
[471] SQUAMOUS CELL CARCINOMA ANTIGEN (SCCA) EXPRESSION AND CD27+ MEMORY B LYMPHOCYTES IN PATIENTS WITH CHRONIC HEPATITIS CVidalino, L. / Quarta, S. / Baesso, I. / Bernardinello, E. / Ruvoletto, M. / Frezzato, F. / Trentin, L. / Fassina, G. / Cavalletto, L. / Chemello, L. et al. | 2007
-
[474] FACTORS ASSOCIATED WITH SEROCLEARANCE OF HEPATITIS B e ANTIGEN: A LONG-TERM FOLLOW-UP STUDYChen, C. A. / Chen, P. J. / Yang, H. I. / Iloeje, U. H. / Su, J. / Jen, C. L. / Yeh, S. H. / Lu, S. N. / You, S. L. / Chen, C. J. et al. | 2007
-
[483] PRESENCE OF BIOPSY-PROVEN HISTOLOGIC DAMAGE (NECROINFLAMMATION AND FIBROSIS) IS COMMON EVEN WHEN ALT IS LESS THAN 2 x ULN IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)Terrault, N. / Kim, R. / Schalm, S. / Lim, S. G. / Papatheodoridis, G. / Alberti, A. / Yuen, M. F. / Goodman, Z. / Vaughan, J. / Wilber, R. et al. | 2007
-
[484] VALIDATION OF THE NEW MELD-Na SCORE IN PREDICTING LONG-TERM SURVIVAL IN PATIENTS WITH CHRONIC HEPATITIS BWong, V. / Chim, A. M. / Wong, G. L. / Sung, J. I. / Chan, H. L. et al. | 2007
-
[500] EFFECTIVENESS OF TWO DIFFERENT DOSES OF INTERFERON ALPHA MONOTHERAPY AND COMBINATION OF LAMIVUDINE FOR THE TREATMENT OF NAIVE CHILDREN WITH CHRONIC HEPATITIS B INFECTIONKocabas, E. / Alabaz, D. / Celik, U. / Alhan, E. / Aksaray, N. / Unal, I. et al. | 2007
-
[537] ANTI-LIVER KIDNEY MICROSOME TYPE ONE (ANTI-LKM1) POSITIVE HCV-RELATED CHRONIC LIVER DISEASE: PRESENTATION AND NATURAL HISTORYFerri, S. / Ballardini, G. / Bianchi, F. B. / Cipriano, V. / De Molo, C. / Granite, A. / Grassi, A. / Muratori, L. / Muratori, P. / Pappas, G. et al. | 2007
-
[543] OUTCOME OF A NURSE-LED OUTREACH SERVICE FOR PRISON INMATES WITH CHRONIC HEPATITIS C INFECTIONGordon, F. H. / Hills, E. B. / Allen, M. / Kitchen, R. / Collins, P. L. / McCune, C. A. et al. | 2007
-
[545] SCH 503034, AN ORAL HCV PROTEASE INHIBITOR, IS WELL-TOLERATED IN PATIENTS WITH VARYING DEGREES OF HEPATIC IMPAIRMENTPreston, R. A. / Alonso, A. B. / Feely, W. / Gupta, S. / Deckman, D. / Marchisin, D. / Kantesaria, B. / Hughes, E. et al. | 2007
-
[552] IV DRUG ABUSE IS MORE IMPORTANT FOR LIVER INJURY THAN HEPATITIS C VIREMIA IN YOUNG ANTI-HCV POSITIVE PATIENTSMeyer, M. F. / Volkmann, X. / Lehmann, M. / Cornberg, M. / Bantel, H. / Manns, M. P. / Wedemeyer, H. et al. | 2007
-
[560] QUANTITATIVE ASSESSMENT OF MITOCHONDRIA BY ULTRASTRUCTURAL METHODS IN CHRONIC HEPATITIS C PATIENTSSmolinski, P. / Gladysz, A. / Nowak, M. / Dolinska-Krajewska, B. et al. | 2007
-
[574] COMPARISON OF EFFICACY OF TREATMENT WITH PEGINTERFERON ALFA PLUS RIBAVIRIN AMONG PATIENTS CHRONICALLY INFECTED WITH NON 2/3 HCV GENOTYPES WITH LOW AND HIGH VIREMIABerak, H. / Kolakowska-Rzadzka, A. / Wasilewski, M. / Kowalska, J. / Stanczak, J. J. / Bardadin, K. / Horban, A. et al. | 2007
-
[596] GENOTYPE-SPECIFIC ASSESSMENT OF PREDICTIVE FACTORS FOR SUSTAINED VIROLOGIC RESPONSE AFTER STANDARD TREATMENT IN PATIENTS CHRONICALLY INFECTED WITH HCVMartens, S. / Weich, V. / Berg, T. / Sarrazin, C. / Hinrichsen, H. / Buggisch, P. / Spengler, U. / Klinker, H. / Zeuzem, S. / Herrmann, E. et al. | 2007
-
[638] INFLUENCE OF INSULIN RESISTANCE AND RIBAVIRIN DOSAGE IN VIRAL DYNAMICS OF PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1 TREATED WITH PEGINTERFERON AND RIBAVIRINGrande, L. / Madrazo, A. / Viloria, M. M. / Nogales, M. C. / Corpas, R. / Camacho, I. / Sanchez-Munoz, D. / Martin-Mazuelos, E. / Romero-Gomez, M. et al. | 2007
-
[641] HOW CAN WE IDENTIFY HCV GENOTYPE 1 PATIENTS WHO MAY BENEFIT FROM AN EXTENDED TREATMENT DURATION WITH PEGINTERFERON a-2a (40 kD) PLUS RBV?Buck, M. / Chojkier, M. et al. | 2007
-
[666] INTRAHEPATIC T-HELPER AND REGULATORY T-CELLS IN AUTOIMMUNE HEPATITIS AND CHRONIC HCV INFECTIONHussain, M. J. / Longhi, M. S. / Mohsen, A. H. / Portmann, B. / Mieli-Vergani, G. / Vergani, D. et al. | 2007
-
[676] GALL BLADDER DISEASE IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITISSaid, K. / Glaumann, H. / Broome, U. / Bergquist, A. et al. | 2007
-
[683] THERAPY OF CHRONIC HEPATITIS C WITH INTERFERON AND RIBAVIRIN - DOES IT INCREASE THE INCIDENCE OF TYPE 2 DIABETES MELLITUS?Hilzenrat, N. / Al-Sayari, K. / Shrier, I. / Kader, T. / Deschenes, M. et al. | 2007
-
[726] METABOLIC CHARACTERISTICS OF LEAN TYPE 2 DIABETES PATIENTS WITH ABNORMAL LIVER ENZYMESLockmann, K. A. / McAvoy, N. C. / Japp, A. J. / Hayes, P. C. et al. | 2007
-
[727] PREDICTORS OF INSULIN RESISTANCE IN NAFLD AND HCVLonardo, A. / Violi, E. / Ballestri, S. / Lombardini, S. / Scaglioni, F. / Ganazzi, D. / Carulli, L. / Ruggiero, G. / Adinolfi, L. E. / Loria, P. et al. | 2007
-
[757] UCP2 INDUCES MITOCHONDRIAL UNCOUPLING DURING NONALCOHOLIC STEATOHEPATITIS: AN ADAPTATIVE MECHANISM TO REDUCE OXIDATIVE STRESS BUT PRODUCING DEPLETION OF ATPServiddio, G. / Bellanti, F. / Tamborra, R. / Romano, A. D. / Rollo, T. / Capitanio, N. / Vendemiale, G. / Altomare, E. et al. | 2007
-
[772] LIPID ACCUMULATION IN HEPATOCYTES INDUCES ACTIVATION AND PRO-FIBROTIC GENE EXPRESSION IN HEPATIC STELLATE CELLS - A NEW IN VITRO MODEL TO STUDY FIBROGENESIS IN NASHWobser, H. / Dorn, C. / Weiss, T. / Bollheimer, C. / Buettner, R. / Schoelmerich, J. / Hellerbrand, C. et al. | 2007
-
[780] NOVEL HEPARANASE INHIBITOR PI-88 EXTENDS DISEASE FREE SURVIVAL IN A RANDOMIZED PHASE II ADJUVANT CLINICAL TRIAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) AFTER CURATIVE RESECTIONChen, P. J. / Lee, P. / Lin, D. Y. / Wu, C. C. / Jeng, L. B. / Lin, P. W. / Mok, K. T. / Gautam, A. M. / Zalcberg, J. R. et al. | 2007
-
EASL New Initiative| 2007
-
[3] A PROSPECTIVE FOLLOW-UP STUDY ON 163 PATIENTS WITH BUDD-CHIARI SYNDROME: RESULTS FROM THE EUROPEAN NETWORK FOR VASCULAR DISORDERS OF THE LIVER (EN-VIE)Murad, S. D. / Plessier, A. / Guerra, M. H. / Primignani, M. / Elias, E. / Bahr, M. / Hadengue, A. / Langlet, P. / Miranda, H. / Pagan, J. C. et al. | 2007
-
[17] CANNABIS USE AS AN INDEPENDENT PREDICTOR OF SEVERE STEATOSIS DURING CHRONIC HEPATITIS CHezode, C. / Zafrani, E. S. / Roudot-Thoraval, F. / Costentin, C. / Hessami, A. / Pawlotsky, J. M. / Lotersztajn, S. / Mallat, A. et al. | 2007
-
[22] THE KLF6 (IVS1-27G > A) POLYMORPHISM IS ASSOCIATED WITH NON-PROGRESSIVE NAFLDMiele, L. / Beale, G. S. / Leathart, J. / Day, C. P. / Reeves, H. L. et al. | 2007
-
[52] LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: VALIDATION OF A NEW PROGNOSTIC SCORE PREDICTING DISEASE-FREE SURVIVALDecaens, T. / Roudot-Thoraval, F. / Badran, H. / Meyer, C. / Durand, F. / Adam, R. / Boillot, O. / Bresson-Hadni, S. / Gugenheim, J. / Dharancy, S. et al. | 2007
-
[66] MOLECULAR BASIS FOR VX-950 RESISTANCEWelsch, C. / Domingues, F. S. / Antes, I. / Susser, S. / Albrecht, M. / Hartmann, C. / Sarrazin, C. / Lengauer, T. / Zeuzem, S. et al. | 2007
-
[90] LONG-TERM IMPROVEMENT OF SERUM SODIUM BY THE V-RECEPTOR ANTAGONIST SATAVAPTAN IN PATIENTS WITH CIRRHOSIS AND HYPONATRAEMIAGines, P. / Wong, F. / Watson, H. et al. | 2007
-
[112] GENETIC VARIATION IN THE RECEPTOR-LIGAND PAIR NKG2D-MICA IS STRONGLY ASSOCIATED WITH DEVELOPMENT OF CHOLANGIOCARCINOMA IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITISMelum, E. / Karlsen, T. H. / Boberg, K. M. / Bergquist, A. / Thorsby, E. / Schrumpf, E. et al. | 2007
-
[145] AUTOCHTHONOUS AND TRAVEL-RELATED HEPATITIS E CASES IN MARSEILLES, FRANCEColson, P. / Henry, M. / Borentain, P. / Motte, A. / Disdier, P. / Coze, C. / Gerolami, R. / Tamalet, C. et al. | 2007
-
[151] BLOODLESS CADAVERIC LIVER TRANSPLANTATION: EXPERIENCE WITH JEHOVAHS WITNESS RECIPIENTSDetry, O. / De Roover, A. / Coimbra, C. / Monnard, J. O. / Hans, M. F. / Delbouille, M. H. / Kaba, A. / Joris, J. / Squifflet, J. P. / Delwaide, J. et al. | 2007
-
[155] HEPATIC VENOUS OUTFLOW OBSTRUCTION AFTER ORTHOTOPIC LIVER TRANSPLANTATION -A SINGLE CENTRE 10 YEAR EXPERIENCEFarid, S. G. / Rehman, J. / Ganti, S. / Al-Mukhtar, A. / Kessel, D. / Patel, J. / Prasad, R. K. et al. | 2007
-
[156] METABOLIC SYNDROME IN LIVER TRANSPLANT RECIPIENTS: INCIDENCE AND RISK FACTORSFrancioso, S. / Almerighi, C. / Angelico, F. / Antonini, T. M. / Telesca, C. / Tisone, G. / Angelico, M. et al. | 2007
-
[171] EXPRESSION OF CXCR AND IP-10 IN RECURRENT HEPATITIS C FOLLOWING LIVER TRANSPLANTATIONPetrovic, L. M. / Chiriboga, L. / Zeremski, M. / Talal, A. et al. | 2007
-
[174] DETECTION OF AUTOANTIBODIES AGAINST CYTOCHROME P450 2E1 (CYP2E1) IN PATIENTS WITH RECURRENT HEPATITIS CRigamonti, C. / Donate, M. F. / Vidali, M. / Serino, R. / Occhino, G. / Ivaldi, A. / Agnelli, F. / Arosio, E. / Rossi, G. / Colombo, M. et al. | 2007
-
[184] LIVER TRANSPLANTARION FOR FAMILIAL AMYLOID POLYNEUROPATHY. TEN YEARS EXPERIENCE OF HOSPITAL ARGERICH (ARGENTINA)Trigo, P. / Varela, E. / Aballay, G. / Braslasky, G. / Cejas, N. / Barros Schelotto, P. / Romero, C. / Oks, A. / Cueto, G. / Rodriguez, D. et al. | 2007
-
[194] EXTRAHEPATIC VASODILATION IN CIRRHOSIS OF BDL RATS: SWITCHING OF(F) VASOCONSTRICTOR RECEPTORS BY GRK-2/BETA-ARRESTIN-2Hennenberg, M. / Trebicka, J. / Sauerbruch, T. / Heller, J. et al. | 2007
-
[201] HYPOXEMIA AND VENOUS ADMIXTURE VIA BRONCHIAL VESSELS IN A RAT MODEL OF HEPATOPULMONARY SYNDROMEMiyamoto, A. / Zhang, X. T. / Ohsuga, M. / Shimizu, S. / Komeichi, H. / Satomura, K. / Akimoto, T. / Nomura, A. / Katsuta, Y. et al. | 2007
-
[203] IGF-1 SUPPLEMENTATION DOES NOT IMPROVE INSULIN ACTION IN CIRRHOSISNielsen, M. F. / Grofte, T. / Greisen, J. / Christiansen, J. S. / Vilstrup, H. et al. | 2007
-
[218] BACTERIAL TRANSLOCATION INDUCES PROINFLAMMATORY CYTOKINES AND WORSENS SYSTEMIC HEMODYNAMICS IN CIRRHOTIC PATIENTS WITH ASCITESBellot, P. / Garcia-Pagan, J. C. / Frances, R. / Abraldes, J. G. / Gonzalez-Navajas, J. M. / Navasa, M. / Perez-Mateo, M. / Such, J. / Bosch, J. et al. | 2007
-
[226] LONG-TERM TREATMENT WITH PEG-IFN-ALFAb REDUCES HEPATOCELLULAR INCIDENCE AND PREVENTS CLINICAL COMPLICATIONS IN HEPATITIS C CIRRHOSIS - AN INTERIM ANALYSIS OF A MULTICENTER TRIALErhardt, A. / Heinzel-Pleines, U. / Boecher, W. / Wedemeyer, H. / Dollinger, M. M. / Albert, F. W. / Witthoeft, T. / Haeussinger, D. et al. | 2007
-
[224] THE IMPACT OF SUSTAINED VIROLOGICAL RESPONSE ON CLINICAL OUTCOMES IN COMPENSATED HCV CIRRHOSIS: A PROSPECTIVE COHORT STUDYDi Marco, V. / Calvaruso, V. / De Lisi, S. / Almasio, P. L. / Ferraro, D. / Peralta, S. / Parisi, P. / Alaimo, G. / Alessi, N. / Di Stefano, R. et al. | 2007
-
[229] CORRELATION BETWEEN SERUM CREATININE, COCKCROFT FORMULA AND DIRECT MEASUREMENT OF GLOMERULAR FILTRATION RATE IN CANDIDATES FOR LIVER TRANSPLANTATION: IMPLICATIONS FOR MELD SCOREFrancoz, C. / Prie, D. / Sobesky, R. / Moreau, R. / Sommacale, D. / Belghiti, J. / Valla, D. / Durand, F. et al. | 2007
-
[240] APPLICABILITY OF NON-INVASIVE METHODS FOR THE DIAGNOSIS OF LIVER INJURY, LIVER STIFFNESS MEASURES (LSM) OR BIOMARKERS, AND FACTORS ASSOCIATED WITH NON-APPLICABILITYMunteanu, M. / Lebray, P. / Fokam, J. M. / de Torres, M. / Ratziu, V. / Benhamou, Y. / Moussalli, J. / Thabut, D. / Poynard, T. et al. | 2007
-
[246] HAPLOTYPES TACG AND CACG FROM GLUTAMINASE GENE PROTECT AGAINST HEPATIC ENCEPHALOPATHYRomero-Gomez, M. / Galan, J. J. / Jover, M. / Camacho, I. / Grande, L. / Trabadela, C. / Hoyas, E. / Ruiz, A. / Bautista, J. D. et al. | 2007
-
[259] RISK OF HEPATOCELLULAR CARCINOMA BY DYNAMIC SEROSTATUS OF HEPATITIS B SURFACE ANTIGENS: A LONG-TERM FOLLOW-UP STUDY AMONG PREGNANT WOMENFwu, C. W. / Chien, Y. C. / Kuo, H. S. / Chen, C. J. et al. | 2007
-
[264] NEW ETIOLOGIC ANALYSIS OF PRIMARY HEPATOCELLULAR CARCINOMA (HCC) BY CLASSIFYING ISOLATED ANTIBODY TO HEPATITIS B CORE ANTIGEN (ANTI-HBC)-POSITIVE CASES AS A SEPARATE CATEGORYKim, B. H. / Choi, S. Y. / Jung, S. H. / Lee, C. K. / Dong, S. H. / Kim, H. J. / Chang, Y. W. / Chang, R. et al. | 2007
-
[283] PML MEDIATES IFN-ALPHA-INDUCED APOPTOSIS IN HEPATOMA CELLSHerzer, K. / Hofmann, T. G. / Boger, R. / Weyer, S. / Krammer, P. M. / Galle, R. R. / Kanzler, S. et al. | 2007
-
[351] ROLE OF PERTURBATION OF METHIONINE METABOLISM AND GLOBAL DNA METHYLATION IN THE GENERATION OF GENOMIC INSTABILITY IN TRANSGENIC MOUSE MODELS OF LIVER CANCERCalvisi, D. F. / Simile, M. M. / Ladu, S. / Pellegrino, R. / De Murtas, V. / Tomasi, M. L. / Virdis, P. / De Miglio, M. R. / Pascale, R. M. / Feo, F. et al. | 2007
-
[377] JunD COOPERATES WITH p65 TO ACTIVATE THE CYCLIN D1 PROMOTER DURING THE SERUM-INDUCED PROLIFERATIVE RESPONSE: ROLE OF PI3KINASE/PDK1Toualbi, K. / Daniel, F. / Giiller, M. C. / Mauriz, T. L. / Legrand, A. / Bernuau, D. et al. | 2007
-
[394] RhoA RNAi INHIBITS THE INVASION AND METASTASIS OF HEPATOCELLULAR CARCINOMA IN VITROWang, B. / Zhang, X. M. / Tian, D. A. et al. | 2007
-
[397] DETERMINATION OF YMDD VARIANTS OF HEPATITIS B VIRUS POLYMERASE GENE BY DENATURING GRADIENT GEL ELECTROPHORESIS (DGGE) - A NOVEL APPROACH TO DRUG RESISTANCE MONITORINGBielawski, K. P. / Al-Soud, W. A. / Stalke, P. / Wadstrom, T. et al. | 2007
-
[401] IMPACT OF MULTIPLE TREATMENT INTERRUPTIONS ON VIRUS-HOST INTERACTIONS IN HBeAg-POSITIVE CHRONIC HEPATITIS B (CHB)Chokshi, S. / Petretto, E. / Cooksley, H. / Mangion, J. / Hill, J. / Naoumov, N. V. et al. | 2007
-
[406] RAPID INSURGENCE OF A VIRAL RESISTANT MUTANT IN WHV CHRONICALLY INFECTED WOODCHUCKS TREATED WITH LAMIVUDINE AND A PRE-S/S CHO-DERIVED HEPATITIS B VIRUS VACCINEDUgo, E. / Kondili, L. / Canitano, A. / Catone, S. / Giusepetti, R. / Gallinella, B. / Palmieri, G. / Orobello, S. / Argentini, C. / Rapicetta, M. et al. | 2007
-
[411] INTERFERON-GAMMA (IFN-y)-INDUCIBLE INTRA-CELLULAR INACTIVATION OF HEPATITIS B VIRUS (HBV): COMPARISON OF APOBEC3 AND NITRIC OXIDE PATHWAYSPhillips, S. / Taylor, J. A. / Chokshi, S. / Navaratnam, N. / Naoumov, N. V. et al. | 2007
-
[442] INHIBITORY EFFECTS OF VARIOUS TYPE IFN ON THE HCVRNA REPLICATION OF HCV REPLICON CELLSFei, R. / Wei, L. / Rao, H. Y. / Cong, X. / Zhu, L. / Liu, F. / Chen, H. S. / Wang, T. H. et al. | 2007
-
[461] ACUTE HEPATITIS C INFECTION IN HIV-INFECTED PATIENTS: LOW RATE OF SPONTANEOUS CLEARANCE AND WEAK HEPATITIS C VIRUS-SPECIFIC T CELL RESPONSESSchnuriger, A. / Dominguez, S. / Katlama, C. / Valantin, M. A. / Simon, A. / Slama, L. / Ouazene, Z. / Girard, P. M. / Autran, B. / Thibault, V. et al. | 2007
-
[476] PREVALENCE OF HBV GENOTYPES IN CENTRAL AND EASTERN EUROPEDeterding, K. / Constantinescu, I. / Gervain, J. / Nemecek, V. / Bielawski, K. P. / Zalewska, M. / Bock, T. / Ambrozaitis, A. / Stanczak, J. / Takacs, M. et al. | 2007
-
[488] WITHDRAWAL FLARES AFTER TREATMENT WITH PEGINTERFERON ALPHA-2b ALONE OR IN COMBINATION WITH LAMIVUDINE IN HBeAg-POSITIVE CHRONIC HEPATITIS BBuster, E. H. / Flink, H. J. / Hansen, B. E. / Janssen, H. L. et al. | 2007
-
[491] EARLY MORTALITY AND RESPONSES IN NONCIRRHOTIC PATIENTS WITH CHRONIC HEPATITIS B-RELATED DECOMPENSATION WITH LAMIVUDINE THERAPY: EVALUATION OF MELD AND INDEX SCORING SYSTEMS AS PROGNOSTIC PREDICTORSDai, C. Y. / Yu, M. L. / Hou, N. T. / Hsieh, M. Y. / Lee, L. P. / Huang, J. F. / Lin, Z. Y. / Chen, S. C. / Wang, L. Y. et al. | 2007
-
[495] VIROLOGIC RESPONSE AT TREATMENT MONTH 12 MAY PREDICT SUSTAINED ANTIVIRAL EFFICACY IN ADEFOVIR TREATED LAMIVUDINE-RESISTANT CHRONIC HEPATITIS BHan, W. S. / Yeon, J. E. / Kim, Y. H. / Oh, S. N. / Seo, Y. S. / Yim, H. J. / Choe, W. H. / Kwon, S. Y. / Byun, K. S. / Lee, C. H. et al. | 2007
-
[544] DETERMINING CURRENT BARRIERS TO ANTIVIRAL TREATMENT IN A COHORT OF U.S. VETERANS REFERRED FOR HCV EVALUATIONDollarhide, A. W. / Groessl, E. / Ho, S. B. et al. | 2007
-
[549] INJURY WITH HEPATITIS C (HCV)-CONTAMINATED NEEDLES IN HEALTH CARE WORKERS: WHAT IS THE TRUE RATE OF SEROCONVERSION?Kubitschke, A. / Bader, C. / Manns, M. P. / Kuhn, S. / Wedemeyer, H. et al. | 2007
-
[558] ASSESSMENT OF FIBROSIS DISTRIBUTION IN PATIENTS WITH CHRONIC HEPATITIS C USING COMPUTER-PERFORMED OPTICAL ANALYSIS OF CT OF THE LIVER (FibroCT)Madrazo, A. / Gomez-Gonzalez, E. / Vera, M. / Castellano, V. / Nevado, M. / Alcon, J. C. / Rodrigo, L. / Perez, R. / Sola, R. / Perez-Moreno, J. M. et al. | 2007
-
[562] CAN FIBROSCAN OVERCOME THE SAMPLING ERROR OF LIVER BIOPSY?Yeshua, H. / Zelber-Sagi, S. / Luria, Y. / Levitt, S. / Brazovski, E. / Kovalev, Y. / Kessler, A. / Webb, M. / Blendis, L. / Brack, R. et al. | 2007
-
[568] HEPATIC FUNCTION IS A STRONG PREDICTIVE FACTOR OF EFFICACY AND SAFETY OF ANTIVIRAL THERAPY IN PORTAL HYPERTENSIVE HEPATITIS C VIRUS-RELATED LIVER CIRRHOSISAnnicchiarico, B. E. / Siciliano, M. / Parente, P. / Gasbarrini, A. / Bombardieri, G. et al. | 2007
-
[583] ACH-806: A POTENT INHIBITOR OF HCV REPLICATION WITH A NOVEL MECHANISM OF ACTIONHuang, M. / Sun, Y. / Yang, W. / Hou, H. / Fabrycki, I. / Nie, X. / Sanchez, A. / Zhao, Y. / Phadke, A. / Deshpande, M. et al. | 2007
-
[633] Withdrawn| 2007
-
[622] R1479, A NOVEL HEPATITIS C POLYMERASE INHIBITOR: LACK OF PRE-EXISTING RESISTANCE MUTATION SUPPORTS THE OBSERVED IN VIVO HIGH BARRIER TO RESISTANCELe Pogam, S. / Kosaka, A. / Hu, S. / Kang, H. / Seshaadri, A. / Symons, J. / Klumpp, K. / Cammack, N. / Najera, I. et al. | 2007
-
[634] A 7 YEAR RETROSPECTIVE AUDIT OF TREATMENT OUTCOMES FOR THE TREATMENT OF HEPATITIS CRehman, J. / Davies, M. H. / Sheridan, S. / Wigglesworth, C. / Moreea, S. / Millson, C. E. et al. | 2007
-
[665] NOVEL ASSAY FOR THE DETECTION OF INTERLEUKIN-17: HIGH POSITIVITY IN PATIENTS WITH AUTOIMMUNE HEPATITISHussain, M. J. / Longhi, M. S. / Mieli-Vergani, G. / Vergani, D. et al. | 2007
-
[673] DEVELOPMENT OF A NOVEL DIAGNOSTIC ASSAY FOR PRIMARY BILIARY CIRRHOSISOertelt-Prigione, S. / Rieger, R. / Selmi, C. / Tnvertiizzi, P. / Podda, M. / Gershwin, M. E. et al. | 2007
-
[699] DIFFERENTIAL EXPRESSION OF GSTT1 AND GSTT2 IS ASSOCIATED WITH MORE ADVANCED FIBROSIS IN PATIENTS WITH NAFLDBeale, G. S. / Miele, L. / Abate, M. L. / Bugianesi, E. / Reeves, H. L. / Day, C. P. et al. | 2007
-
[729] SERUM LEPTIN CONCENTRATIONS IN CHRONIC VIRAL HEPATITIS: A CLINICAL APPROACHManolakopoulos, S. / Bethanis, S. / Liapi, C. / Sklavos, P. / Stripeli, F. / Margeli, A. / Christidou, A. / Katsanika, A. / Vogiatzakis, E. / Tzourmakliotis, D. et al. | 2007
-
[741] CYCLOOXYGENASE-2 INHIBITORS ATTENUATE THE SEVERITY OF GALACTOSAMINE-LIPOPOLYSACCHARIDE INDUCED ACUTE LIVER INJURY IN MICETipoe, G. L. / Liong, B. C. / Leung, T. M. / Lau, T. Y. / Nanji, A. A. et al. | 2007
-
[775] OVEREXPRESSION OF PIGMENT EPITHELIUM-DERIVED FACTOR PREVENTS FAT STORAGE, INFLAMMATION AND NEOPLASTIC FORMATION IN THE LIVER OF MICE STEATOHEPATITIS MODELYoshida, T. / Yamagishi, S. / Koga, H. / Nakamura, K. / Matsui, T. / Imaizumi, T. / Ueno, T. / Sata, M. et al. | 2007
-
[778] AMELIORATION OF NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND THE METABOLIC SYNDROME IN DIABETIC COHEN RATS IS ASSOCIATED WITH REDUCED PANCREATIC INJURYZigmond, E. / Zangen, S. W. / Pappo, O. / Zolotarov, L. / Raz, I. / Ilan, Y. / Margalit, M. et al. | 2007
-
[786] RESULTS OF AN INTERIM ANALYSIS OF A PHASE 2 STUDY OF TELAPREVIR (VX-950) WITH PEGINTERFERON a-2a AND RIBAVIRIN IN PREVIOUSLY UNTREATED SUBJECTS WITH HEPATITIS CMcHutchison, J. G. / Everson, G. T. / Gordon, S. / Jacobson, I. / Kauffman, R. / McNair, L. / Muir, A. et al. | 2007
-
[794] WHAT IS THE ROLE OF HBV RTA181V/T MUTANTS IN HEPATITIS B TREATMENT FAILURE?Villet, S. / Pichoud, C. / Billioud, G. / Trepo, C. / Zoulim, F. et al. | 2007
-
Editorial Board| 2007
-
EASL Backed Meetings| 2007
-
EASL Clinical School of Hepatology| 2007
-
43rd Annual Meeting of EASL| 2007
-
[9] COMPARABLE ANTIVIRAL RESPONSE RATES WITH ALBUMIN INTERFERON ALFA-2B DOSED AT Q2W OR Q4W INTERVALS IN NAIVE SUBJECTS WITH GENOTYPE 2 OR 3 CHRONIC HEPATITIS CBain, V. G. / Marotta, P. / Kaita, K. / Yoshida, E. / Swain, M. / Bailey, R. / Neumann, A. / Cronin, P. / McHutchison, J. / Pulkstenis, E. et al. | 2007
-
[50] ANTIVIRAL ACTIVITY OF THE NON-NUCLEOSIDE POLYMERASE INHIBITOR, HCV-796, IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2b IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCVVillano, S. A. / Raible, D. / Harper, D. / Speth, J. / Chandra, P. / Shaw, P. / Bichier, G. et al. | 2007
-
[55] COMPLEX DYNAMICS OF HEPATITIS B VIRUS RESISTANCE TO ADEFOVIR DIPIVOXILPallier, C. / Rodriguez, C. / Brillet, R. / Hezode, C. / Pawlotsky, J. M. et al. | 2007
-
[57] 3 YEARS OF ADEFOVIR AND LAMIVUDINE COMBINATION THERAPY MINIMIZES THE RISK OF GENOTYPIC RESISTANCE TO ADV IN LAM RESISTANT PATIENTSLampertico, P. / Vigano, M. / Manenti, E. / Tavarone, M. / Lunghi, G. / Del Ninno, E. / Colombo, M. et al. | 2007
-
[79] ACUTE HEMODYNAMIC RESPONSE TO BETA-BLOCKERS FOR THE PREDICTION OF LONG-TERM OUTCOME IN PRIMARY PROPHYLAXIS OF VARICEAL BLEEDING. FINAL RESULTS OF A PROSPECTIVE STUDYAracil, C. / Colomo, A. / Ordas, I. / Guarner, C. / Torras, X. / Gallego, A. / Villanueva, C. / Balanzo, J. et al. | 2007
-
[123] SUSTAINED VIROLOGICAL RESPONSE RATES WITH PEGINTERFERON a-2a (40 kD) (PEGASYS) PLUS RIBAVIRIN (COPEGUS) IN RANDOMISED CONTROLLED CLINICAL TRIALS ARE REPLICATED IN THE CLINICAL PRACTICE SETTINGAlberti, A. / Zehnter, E. / Lee, S. S. / Hadziyannis, S. J. / Zeuzem, S. / Rizzetto, M. / Diago, M. et al. | 2007
-
[134] HYPOXIA-INDUCIBLE FACTOR 1 ALPHA (HIF1) SENSES RAPID HEPATIC OXYGEN DROPS BUT NOT LIVER HYPOXIA IN GENERAL DUE TO AN ADAPTIVE AUTO-LOOP WITH PROLYL HYDROXYLASE 2Millonig, G. / Hegedusch, S. / Becker, L. / Schuppan, D. / Mueller, S. et al. | 2007